Other specified/unspecified inflammatory spondylopathies

M13_SPONDYLINFLAMNAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M46.8, M46.9 Hospital discharge: ICD-9 — 720[8-9] Cause of death: ICD-10 — M46.8, M46.9 Cause of death: ICD-9 — 720[8-9] 2 out of 7 registries used, show all original rules.	2235
4. Check minimum number of events None	2235
5. Include endpoints None	2235
6. Filter based on genotype QC (FinnGen only)	2062

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_SPONDYLINFLAMNAS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M46[8-9]
HD_ICD_9	720[8-9]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M46[8-9]
COD_ICD_9	720[8-9]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specified/unspecified inflammatory spondylopathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11100	6611	4434
Only index persons	10586	6400	4186
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.12
Only index persons	0.21	0.24	0.16
Median age at first event (years)
Whole population	43.02	42.94	43.03
Only index persons	42.21	42.34	42.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2062	1390	672
Unadjusted period prevalence (%)	0.43	0.49	0.31
Median age at first event (years)	43.76	43.02	45.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2130: Matched controls
21300

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

13.2

310.9

314

275

H02AB06

ATC

prednisolone; systemic

5.5

307.9

1501

6409

P01BA02

ATC

hydroxychloroquine; oral

8.6

307.7

507

745

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

471.2

307.7

476

L04AB04

ATC

adalimumab; parenteral

30.0

307.7

439

183

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

49.0

307.7

712

216

L88

ICPC

Rheumatoid/seropositive arthritis

21.8

307.7

510

303

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

71.0

307.7

176

L04AB01

ATC

etanercept; parenteral

37.2

307.7

321

101

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

27.5

307.7

404

180

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

147.2

307.7

356

M13.9

ICD-10 Finland

Arthritis, unspecified

11.7

307.7

567

643

L01BA01

ATC

methotrexate; systemic

19.1

307.7

378

238

A07EC01

ATC

sulfasalazine; oral, rectal

73.7

307.7

1462

614

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

24.4

307.7

302

143

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

4503599627370496.0

307.7

1910

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

30.4

307.7

438

180

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

16.2

307.7

681

600

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

51.1

307.7

1521

993

M45

ICD-10 Finland

Ankylosing spondylitis

955.5

307.7

822

M48.0

ICD-10 Finland

Spinal stenosis

34.3

307.7

208

L04AX03

ATC

methotrexate; systemic

22.5

307.7

1093

952

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

16.5

307.7

413

306

L04AB06

ATC

golimumab; parenteral

72.7

307.7

198

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

51.5

307.7

696

199

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

14.2

307.7

581

547

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

47.0

307.1

181

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

+∞

266.4

250

M54.9

ICD-10 Finland

Dorsalgia, unspecified

6.6

240.7

447

825

M79.0

ICD-10 Finland

Rheumatism, unspecified

16.3

227.3

198

133

N03AX16

ATC

[U] pregabalin

5.1

227.1

603

1534

M54.5

ICD-10 Finland

Low back pain

4.1

224.8

1013

3837

L04AA13

ATC

[U] leflunomide

14.9

222.8

204

150

N03AX12

ATC

[U] gabapentin; oral

6.3

221.9

431

828

M01AH01

ATC

celecoxib; oral

5.1

218.0

576

1455

L04AC10

ATC

secukinumab; parenteral

56.7

217.7

123

M01AC06

ATC

meloxicam; systemic, rectal

3.9

210.2

1053

4247

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

7.7

207.3

318

477

M54.4

ICD-10 Finland

Lumbago with sciatica

5.4

202.4

471

1063

N02AX02

ATC

tramadol; systemic, rectal

3.8

201.2

1061

4400

L04AB05

ATC

certolizumab pegol; parenteral

45.0

200.4

119

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

12.7

195.9

197

169

M01AH05

ATC

etoricoxib; oral

4.5

187.3

1697

9887

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

22.3

185.4

138

M47.82

ICD-10 Finland

Other spondylosis, cervical region

25.8

183.9

129

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

16.1

183.6

160

107

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

11.3

178.7

195

189

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

10.0

167.0

199

218

M47.9

ICD-10 Finland

Spondylosis, unspecified

65.5

159.9

M25.5

ICD-10 Finland

Pain in joint

3.3

154.8

1013

4626

WZA10

NOMESCO Finland

Extensive medical or dental certificate

15.4

149.5

133

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

144.4

1127

5638

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

18.8

142.4

114

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

70.6

137.8

H20.1

ICD-10 Finland

Chronic iridocyclitis

17.9

133.2

109

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

21.6

131.9

N06AX21

ATC

duloxetine; oral

4.5

131.0

366

941

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

14.2

130.5

121

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

10.2

127.6

147

153

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

13.8

126.2

119

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.9

125.5

1090

5656

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.0

124.6

814

3620

UJF32

NOMESCO Finland

Coloscopy

3.2

121.4

645

2544

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

33.2

119.9

M43.1

ICD-10 Finland

Spondylolisthesis

20.8

112.9

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

14.9

112.3

101

L03

ICPC

Low back symptom/complaint

2.9

110.3

740

3301

A02BC02

ATC

pantoprazole; systemic

3.0

109.2

1577

10374

M79.7

ICD-10 Finland

Fibromyalgia

7.8

104.3

149

203

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

9.9

103.0

121

129

M54.6

ICD-10 Finland

Pain in thoracic spine

4.9

102.9

246

554

NH3EA

NOMESCO Finland

Feet X-ray examination with load

9.9

100.3

118

126

A02BC03

ATC

lansoprazole; oral

2.8

97.7

662

2939

M54.2

ICD-10 Finland

Cervicalgia

5.0

97.6

225

491

M03BX02

ATC

tizanidine; oral

2.7

97.5

1504

9945

M03BC01

ATC

orphenadrine (citrate); systemic

2.9

96.5

598

2530

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.8

96.4

330

974

N06AA09

ATC

amitriptyline; systemic

4.6

89.9

230

546

M35.7

ICD-10 Finland

Hypermobility syndrome

12.3

89.7

M01AH02

ATC

rofecoxib; oral

4.0

89.1

285

800

N02BF01

ATC

gabapentin; oral

4.3

88.7

249

635

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.0

86.9

197

423

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

10.9

86.2

NG1DA

NOMESCO Finland

X-ray of knees

12.4

86.1

M54.3

ICD-10 Finland

Sciatica

7.0

85.1

134

203

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

50.1

84.5

S01BA04

ATC

prednisolone; ophthalmic

8.8

82.9

106

126

M70.6

ICD-10 Finland

Trochanteric bursitis

3.5

81.6

319

1023

M54.1

ICD-10 Finland

Radiculopathy

10.4

81.0

S01BA01

ATC

dexamethasone; ophthalmic

6.2

77.5

138

237

WZC30

NOMESCO Finland

Teaching

2.9

77.2

450

1819

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.5

76.2

200

483

M01AX01

ATC

nabumetone; oral

6.5

73.4

124

202

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

73.4

M01AB05

ATC

diclofenac; systemic, rectal

2.4

73.2

1493

10523

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

72.5

616

2992

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

72.3

M01AB55

ATC

diclofenac, combinations; oral

5.1

72.2

158

328

N02AJ06

ATC

codeine and paracetamol; systemic

2.3

71.6

977

5814

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

11.4

70.4

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

13.9

70.1

L40.5

ICD-10 Finland

Arthropathic psoriasis

8.5

70.0

113

XX9XE

NOMESCO Finland

Other ultrasound examination

14.4

69.2

A02BC01

ATC

omeprazole; systemic

2.5

68.9

587

2845

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

10.6

68.8

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

25.8

68.8

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

68.5

770

4211

M01AE02

ATC

naproxen; oral, rectal

2.2

68.4

1334

9106

L86

ICPC

Back syndrome with radiating pain

5.3

68.0

141

279

M13.8

ICD-10 Finland

Other specified arthritis

11.5

66.8

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.4

66.5

265

855

M79.6

ICD-10 Finland

Pain in limb

2.2

65.7

1002

6172

L04AC13

ATC

ixekizumab; parenteral

32.9

65.1

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

11.3

64.3

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

11.3

64.3

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

7.0

64.3

100

149

M50.3

ICD-10 Finland

Other cervical disc degeneration

17.0

63.5

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.1

63.5

305

1100

A02BC05

ATC

esomeprazole; systemic

2.2

62.6

876

5192

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

13.9

61.5

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

87.8

61.3

H02AB07

ATC

prednisone; oral

2.9

60.9

330

1271

M54

ICD-10 Finland

Dorsalgia

2.8

60.3

340

1338

M01CB01

ATC

sodium aurothiomalate; parenteral

12.0

60.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

60.1

867

5180

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

+∞

59.7

L04AA11

ATC

[U] etanercept

25.2

59.6

N02BE01

ATC

paracetamol; systemic, rectal

3.3

58.9

1934

15993

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

58.9

546

2724

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

12.4

58.4

L04AX01

ATC

azathioprine; systemic

4.4

58.2

155

377

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

14.8

58.0

TNG10

NOMESCO Finland

Puncture of knee

10.0

57.4

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

6.0

56.9

102

176

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.1

56.6

905

5588

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

11.2

56.5

M01AX17

ATC

nimesulide; oral

2.4

56.0

452

2115

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

9.1

56.0

A01

ICPC

Pain general/multiple sites

3.3

55.8

233

771

7209X

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Unspecified inflammatory spondylopathy

+∞

55.5

R51.80

ICD-10 Finland

Headache

2.5

54.7

418

1906

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.9

54.7

280

1043

R4110

NOMESCO Finland

Physiotherapy

2.2

54.5

595

3163

H57.1

ICD-10 Finland

Ocular pain

4.1

54.3

154

393

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

13.8

53.7

S01FA04

ATC

cyclopentolate; ophthalmic

10.6

53.6

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

53.3

484

2381

L04AB02

ATC

infliximab; parenteral

12.7

53.1

M13.0

ICD-10 Finland

Polyarthritis, unspecified

8.5

52.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

52.7

961

6176

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

52.7

661

3705

N02BF02

ATC

pregabalin; oral

3.9

52.6

163

443

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

6.8

52.0

127

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.7

51.4

309

1251

M46.0

ICD-10 Finland

Spinal enthesopathy

266.9

51.3

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

10.4

51.2

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.2

51.1

526

2721

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

11.8

50.8

NF1AA

NOMESCO Finland

Hip X-ray examination

3.7

50.6

173

503

SPAT1301

SPAT

No procedures

2.1

50.6

621

3442

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

50.5

506

2587

J01AA02

ATC

doxycycline; systemic

2.2

50.0

1651

12994

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.4

49.8

418

1981

ZX120

NOMESCO Finland

Intravenous

3.0

49.3

241

873

J01FF01

ATC

clindamycin; systemic

2.1

49.0

604

3347

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.7

48.8

170

A07EC02

ATC

mesalazine; oral, rectal

3.6

48.6

172

512

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

90.6

48.0

M54.8

ICD-10 Finland

Other dorsalgia

4.6

47.8

118

270

R52.2

ICD-10 Finland

Other chronic pain

5.2

47.5

100

200

M46.4

ICD-10 Finland

Discitis, unspecified

478.2

47.5

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.7

46.4

152

429

A02BA02

ATC

ranitidine; systemic

2.4

46.4

359

1637

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

46.1

660

3852

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

45.7

598

3376

A07EA06

ATC

budesonide; oral, local oral

4.1

45.4

129

329

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.4

45.3

171

530

ZYC01

NOMESCO Finland

Remote contact by phone

3.3

45.1

185

604

N02AC04

ATC

dextropropoxyphene; oral

7.2

45.0

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

44.6

842

5392

M01AH03

ATC

valdecoxib; oral

3.8

43.2

137

378

ZX140

NOMESCO Finland

Intra articular

10.4

43.2

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

17.8

42.9

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

42.8

720

4423

G44.2

ICD-10 Finland

Tension-type headache

2.4

42.7

336

1540

M01CB03

ATC

auranofin; oral

14.9

42.6

R06.0

ICD-10 Finland

Dyspnoea

2.1

42.6

518

2836

L20

ICPC

Joint symptom/complaint NOS

4.1

42.3

119

301

H20

ICD-10 Finland

Iridocyclitis

12.6

41.9

H15.1

ICD-10 Finland

Episcleritis

6.5

41.5

107

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.5

41.2

304

1351

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

40.8

L84

ICPC

Back syndrome without radiat pain

3.9

40.6

122

324

S01FA02

ATC

scopolamine; ophthalmic

12.3

40.2

G54.0

ICD-10 Finland

Brachial plexus disorders

5.6

40.0

142

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

7.7

40.0

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.4

39.9

151

468

J01DB01

ATC

cefalexin; oral

2.2

39.6

1793

15029

L01

ICPC

Neck symptom/complaint

2.2

39.5

380

1892

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.6

39.5

135

392

L28

ICPC

Limited function/disability (L)

2.4

39.4

300

1351

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

12.4

39.3

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.8

39.2

194

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

39.2

185

655

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.8

39.2

210

797

N06AX16

ATC

venlafaxine; oral

2.3

39.0

350

1694

Z3226

NOMESCO Finland

Physiotherapist

2.3

38.7

356

1739

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

38.4

580

3413

4AB02, ,

NOMESCO Finland

14.2

38.3

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.2

38.2

161

533

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

9.6

38.1

L17

ICPC

Foot/toe symptom/complaint

1.9

37.9

626

3794

SPAT1202

SPAT

Intra-articular injection

6.0

37.9

114

M01AB08

ATC

etodolac; oral

3.1

37.6

163

549

R50.9

ICD-10 Finland

Fever, unspecified

2.2

37.5

350

1719

NF1DA

NOMESCO Finland

X-ray of hips

7.2

37.4

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

37.0

516

2948

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

36.7

309

1453

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

36.4

453

2485

Z71.8

ICD-10 Finland

Other specified counselling

1.8

36.3

780

5123

J01MA02

ATC

ciprofloxacin; systemic

1.8

36.2

733

4728

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

36.1

498

2831

R52.9

ICD-10 Finland

Pain, unspecified

2.6

35.9

230

954

SPAT1263

SPAT

Sampling

1.8

35.8

850

5746

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

35.7

395

2071

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

35.5

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

7.8

35.3

M02AA07

ATC

piroxicam; topical

1.9

35.3

635

3939

M02.8

ICD-10 Finland

Other reactive arthropathies

11.8

35.2

M06

ICD-10 Finland

Other rheumatoid arthritis

10.4

35.2

Z50.1

ICD-10 Finland

Other physical therapy

3.6

34.7

117

336

S18

ICPC

Laceration/cut

1.8

34.5

890

6145

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

+∞

34.5

M07.3

ICD-10 Finland

Other psoriatic arthropathies

7.6

34.4

L13

ICPC

Hip symptom/complaint

2.2

34.1

347

1759

XA402

NOMESCO Finland

ENMG

6.6

34.1

R03AC02

ATC

salbutamol; inhalant

1.7

34.0

1177

8820

M35.3

ICD-10 Finland

Polymyalgia rheumatica

4.7

34.0

172

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

13.5

34.0

ZXH09, ,

SPAT

4.0

33.8

258

L99

ICPC

Musculoskeletal disease other

5.1

33.7

146

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

6.3

33.6

L02

ICPC

Back symptom/complaint

2.4

33.5

250

1113

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

+∞

33.4

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.8

33.1

103

280

R42

ICD-10 Finland

Dizziness and giddiness

2.0

33.1

414

2267

ZYC01, ,

SPAT

2.3

32.9

281

1326

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

32.9

234

1019

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

32.9

291

1394

N02AA05

ATC

oxycodone; systemic

2.3

32.6

266

1231

K02.1

ICD-10 Finland

Caries of dentine

1.8

32.6

1358

10666

M76.6

ICD-10 Finland

Achilles tendinitis

3.5

32.5

115

341

SPAT1153

SPAT

Removal of sutures

1.9

32.5

549

3325

M01AE52

ATC

naproxen and esomeprazole; oral

4.2

32.2

209

M02AA10

ATC

ketoprofen; topical

2.2

32.2

306

1509

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

5.8

32.2

104

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

32.0

489

2864

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.8

32.0

H02AB04

ATC

methylprednisolone; systemic

2.2

31.8

292

1419

P01AB01

ATC

metronidazole; oral, rectal

1.7

31.5

854

5940

7208A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Other inflammatory spondylopathies

+∞

31.3

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.5

31.2

114

N06AX11

ATC

mirtazapine; oral

1.8

31.2

686

4494

C07AB07

ATC

bisoprolol; oral

1.7

31.0

767

5193

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

30.9

296

1462

ZXH06, ,

SPAT

3.1

30.4

133

450

K07.60

ICD-10 Finland

Snapping jaw

2.9

30.2

149

539

SPAT1260

SPAT

Consultation of another employee

2.1

30.1

333

1738

D07AC01

ATC

betamethasone; topical

1.7

30.0

745

5038

WZC00, ,

SPAT

2.1

29.9

329

1713

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

157.2

29.7

N02AJ13

ATC

tramadol and paracetamol; systemic

5.9

29.7

E0000UV, ,

ATC

1.7

29.5

897

6403

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.2

29.4

119

384

ZY010, ,

SPAT

6.1

29.4

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

6.1

29.4

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

+∞

29.2

SFA20

NOMESCO Finland

Two-surface restoration

1.7

28.9

1321

10467

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

28.3

28.9

J01FA10

ATC

azithromycin; systemic

1.7

28.9

1280

10060

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

28.7

165

647

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

104.8

28.7

L04AA01

ATC

[U] ciclosporin

6.6

28.6

J02AC01

ATC

fluconazole; systemic

1.7

28.6

889

6370

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

28.4

1517

12504

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.5

28.4

102

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

28.3

366

2019

R03DC03

ATC

montelukast; oral

2.0

28.2

370

2051

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

28.1

1561

12987

G47.3

ICD-10 Finland

Sleep apnoea

1.9

28.0

462

2760

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.5

28.0

284

R4120

NOMESCO Finland

Occupational therapy

2.7

27.8

152

581

SPAT1310

SPAT

Counselling related to known health issue

1.8

27.8

605

3927

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

6.5

27.8

ACC51

NOMESCO Finland

Release of median nerve

2.6

27.8

165

658

UJF92

NOMESCO Finland

Capsular endoscopy

4.7

27.6

139

R03AC03

ATC

terbutaline; inhalant

2.1

27.6

307

1602

B01AB05

ATC

enoxaparin; parenteral

1.8

27.5

558

3546

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

7.6

26.8

M01AC01

ATC

piroxicam; systemic, rectal

2.3

26.8

226

1058

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.1

26.5

115

387

M25.9

ICD-10 Finland

Joint disorder, unspecified

6.2

26.3

J01DA01

ATC

[U] cefalexin

1.6

26.2

1257

9967

M79.1

ICD-10 Finland

Myalgia

2.0

26.2

338

1859

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.4

26.1

187

815

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.2

25.9

227

1078

ZXA05

NOMESCO Finland

Left side

1.9

25.7

394

2294

L04AK01

ATC

leflunomide; oral

8.2

25.7

J01FA06

ATC

roxithromycin; oral

1.7

25.6

777

5490

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

6.6

25.6

K50.8

ICD-10 Finland

Other Crohn disease

4.9

25.6

116

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

33.5

25.6

M43.0

ICD-10 Finland

Spondylolysis

33.5

25.6

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.9

25.3

117

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

25.3

208

962

SPAT1229

SPAT

Assessment of need for aid

3.0

25.3

118

414

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.6

25.3

244

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

25.1

642

4335

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

25.0

R01AD09

ATC

mometasone; nasal

1.6

25.0

997

7522

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.7

24.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

24.7

374

2167

J01CA04

ATC

amoxicillin; systemic

1.9

24.6

1771

15486

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

24.6

746

5259

M05BA04

ATC

alendronic acid; oral

2.7

24.5

135

518

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

24.4

1579

13377

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

5.2

24.3

WZC30, ,

SPAT

2.4

24.3

179

789

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

24.1

274

1439

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

24.0

170

736

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.9

23.9

111

R4180

NOMESCO Finland

Podiatric therapy

6.0

23.9

R07.3

ICD-10 Finland

Other chest pain

2.3

23.8

196

907

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

23.8

380

2237

ZXA00

NOMESCO Finland

Right side

1.8

23.8

416

2518

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

23.8

384

2268

SFA10

NOMESCO Finland

One-surface restoration

1.6

23.6

1197

9513

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

23.4

853

6267

L15

ICPC

Knee symptom/complaint

1.7

23.3

485

3086

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

23.2

219

1070

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

23.1

481

3060

M01AB01

ATC

indometacin; systemic, rectal

2.9

23.1

109

385

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.4

23.1

264

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.2

23.0

202

959

9211

FHL

Exploration or removal of diskusprolapse

+∞

23.0

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

22.7

142

580

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

4.7

22.7

112

L16

ICPC

Ankle symptom/complaint

2.0

22.6

263

1390

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.6

22.6

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

22.6

254

1327

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.0

22.6

N05BA01

ATC

diazepam; systemic, rectal

2.1

22.3

236

1205

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.7

22.0

198

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

22.0

284

1556

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

21.7

628

4346

R06AE07

ATC

cetirizine; oral

1.6

21.6

936

7118

Z01.2

ICD-10 Finland

Dental examination

1.6

21.6

1017

7881

C08CA01

ATC

amlodipine; oral

1.7

21.6

564

3804

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

21.5

751

5436

M01AE01

ATC

ibuprofen; systemic, rectal

2.2

21.4

1954

17837

NDL52

NOMESCO Finland

Tenosynovectomy of hand

8.3

21.4

H02BX01

ATC

methylprednisolone, combinations; systemic

3.3

21.3

247

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

21.2

189

902

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

21.2

1096

8657

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

34.2

21.1

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.7

21.0

120

469

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

16.7

20.9

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

20.9

136

566

M46

ICD-10 Finland

Other inflammatory spondylopathies

+∞

20.9

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

24.5

20.9

L04AA17

ATC

[U] adalimumab

21.7

20.8

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

77.6

20.7

M53.2

ICD-10 Finland

Spinal instabilities

77.6

20.7

AA1AD

NOMESCO Finland

CT of head and brain

1.7

20.5

428

2714

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

20.5

155

691

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

20.5

203

1011

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.3

20.2

J04AB02

ATC

rifampicin; systemic

6.3

20.2

SFA30

NOMESCO Finland

Three-surface restoration

1.5

20.0

865

6545

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

19.0

20.0

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.1

19.9

289

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.5

19.9

133

561

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

+∞

19.8

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.8

19.8

N06AA10

ATC

nortriptyline; systemic

4.6

19.7

105

H20.8

ICD-10 Finland

Other iridocyclitis

8.2

19.6

ZXE00

NOMESCO Finland

One hour or less

1.6

19.5

747

5494

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

19.4

257

1418

R03BA02

ATC

budesonide; inhalant

1.8

19.4

363

2229

TQW40, ,

SPAT

2.1

19.3

205

1046

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

19.3

1155

9336

OAB42, ,

SPAT

1.9

19.3

280

1591

M19.2

ICD-10 Finland

Other secondary arthrosis

5.8

19.3

Z3231

NOMESCO Finland

Registered nurse

1.7

19.3

476

3150

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

19.1

165

778

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

22.8

19.1

N05CF01

ATC

zopiclone; oral

1.6

19.0

533

3641

ZXA10

NOMESCO Finland

Bilateral

1.8

19.0

295

1713

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

19.0

241

1311

L04AC21

ATC

bimekizumab; systemic

55.5

18.9

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.3

18.9

152

695

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.6

18.9

114

458

ZY010

NOMESCO Finland

Hospital outpatient

2.4

18.9

131

562

X58

ICD-10 Finland

Exposure to other specified factors

1.8

18.8

310

1832

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

18.8

208

1078

M17.5

ICD-10 Finland

Other secondary gonarthrosis

5.0

18.8

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

18.7

309

1828

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

18.7

426

2760

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.0

18.6

131

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

18.6

433

2821

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

5.4

18.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

18.6

506

3430

R02

ICPC

Shortness of breath/dyspnoea

2.0

18.5

220

1169

N05BA04

ATC

oxazepam; oral

1.6

18.5

484

3246

R01AD12

ATC

fluticasone furoate; nasal

1.5

18.5

714

5246

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

18.4

1197

9804

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

18.4

584

4103

R74

ICPC

Upper respiratory infection acute

1.5

18.4

781

5855

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

18.4

170

823

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.9

18.3

303

L08

ICPC

Shoulder symptom/complaint

1.7

18.3

420

2725

NA2BG, ,

SPAT

7.2

18.2

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.5

18.2

118

490

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

18.2

959

7517

A01AB09

ATC

miconazole; local oral

2.3

18.2

149

687

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

18.1

162

774

XKD00

NOMESCO Finland

Uroflowmetry

2.1

17.9

175

865

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.0

17.9

274

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

17.9

571

4012

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

4.4

17.8

105

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

26.9

17.8

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

17.8

104

411

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

18.2

17.8

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.1

17.8

171

841

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

17.7

356

2228

M70.7

ICD-10 Finland

Other bursitis of hip

3.9

17.6

137

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

181.5

17.5

C03CA01

ATC

furosemide; systemic

1.7

17.4

337

2085

F01

ICPC

Eye pain

3.1

17.4

236

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.8

17.4

138

L04AD01

ATC

ciclosporin; systemic

3.9

17.4

129

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

5.4

17.3

WX290

NOMESCO Finland

Other blockage of nerve

1.5

17.3

1078

8708

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

17.3

190

982

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

17.3

146

682

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

17.2

255

1458

D07AD01

ATC

clobetasol; topical

1.7

17.2

323

1982

D01

ICPC

Abdominal pain/cramps general

1.8

17.2

256

1466

N03AE01

ATC

clonazepam; systemic

2.6

17.1

100

395

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

17.1

287

SPAT1255

SPAT

Intravenous administration of medicine

2.4

17.1

116

493

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

31.7

17.0

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

17.0

838

6452

M02.1

ICD-10 Finland

Postdysenteric arthropathy

16.1

17.0

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.0

17.0

250

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.3

17.0

105

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

16.9

156

754

R1250

NOMESCO Finland

Evaluation of functional capability

3.7

16.9

150

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.6

16.9

155

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.1

16.9

230

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.4

16.8

C01CA24

ATC

epinephrine; parenteral

2.1

16.8

156

756

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

16.8

186

963

L12

ICPC

Hand/finger symptom/complaint

1.7

16.8

338

2113

UKC02

NOMESCO Finland

Cystoscopy

2.0

16.8

202

1078

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

63.8

16.7

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.9

16.7

128

K30

ICD-10 Finland

Functional dyspepsia

1.9

16.7

225

1247

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

5.5

16.7

SPAT1325

SPAT

Vaccination

1.6

16.7

520

3627

RF120, ,

NOMESCO Finland

6.5

16.7

R06AX27

ATC

desloratadine; oral

1.5

16.6

646

4731

N04BC05

ATC

pramipexole; oral

2.4

16.6

114

487

R21

ICPC

Throat symptom/complaint

1.6

16.5

488

3361

R5599

NOMESCO Finland

Other rehabilitation service

3.8

16.4

130

J01FA09

ATC

clarithromycin; systemic

1.5

16.4

610

4423

R00.2

ICD-10 Finland

Palpitations

2.0

16.4

177

909

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

16.4

353

2247

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.9

16.3

272

A02BX02

ATC

sucralfate; oral

3.2

16.3

203

L29

ICPC

Musculoskeletal sympt/complt other

2.1

16.3

161

799

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

16.3

432

2897

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

16.3

214

R01AD08

ATC

fluticasone; nasal

1.5

16.2

599

4333

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

5.1

16.2

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

16.2

183

955

C07AB02

ATC

metoprolol; systemic

1.8

16.1

261

1531

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.7

16.1

D05AX52

ATC

calcipotriol, combinations; topical

2.4

16.1

112

481

K51.5

ICD-10 Finland

Left sided colitis

2.9

16.1

269

R53

ICD-10 Finland

Malaise and fatigue

1.6

16.1

481

3319

R51

ICD-10 Finland

Headache

2.2

16.0

134

623

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

5.0

15.9

A07AA02

ATC

nystatin; oral

2.5

15.9

398

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

15.9

329

2071

EB1VA, ,

NOMESCO Finland

1.6

15.9

381

2492

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

15.8

273

1633

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

15.8

251

1465

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.5

15.7

101

418

C01DA14

ATC

isosorbide mononitrate; oral

2.2

15.7

142

681

R10.0

ICD-10 Finland

Acute abdomen

2.9

15.7

256

C07AA05

ATC

propranolol; systemic

1.6

15.7

409

2729

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

15.7

553

3956

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

15.7

194

1045

D07XC01

ATC

betamethasone; topical

1.9

15.6

221

1243

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

15.6

C10AC01

ATC

colestyramine; oral

3.3

15.6

178

WX402

NOMESCO Finland

General anaesthesia

1.6

15.6

438

2975

J20

ICD-10 Finland

Acute bronchitis

1.9

15.6

206

1134

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

15.5

194

1049

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

15.4

521

3690

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

15.4

123

561

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.8

15.4

298

WX002

NOMESCO Finland

Sedation and analgesia

1.7

15.4

302

1872

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

38.3

15.4

A03

ICPC

Fever

1.6

15.3

381

2511

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.0

15.3

222

R01AD58

ATC

fluticasone, combinations; nasal

1.5

15.3

574

4160

L18

ICPC

Muscle pain

2.6

15.2

335

N06AB04

ATC

citalopram; systemic

1.6

15.2

369

2419

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.6

15.2

359

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.2

15.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

15.1

221

1257

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

15.1

151

754

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.3

15.0

J01CF05

ATC

flucloxacillin; systemic

2.1

15.0

150

748

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

15.0

139

674

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.0

14.9

180

962

UDC00

NOMESCO Finland

Ear microscopy

2.1

14.9

144

710

R09

ICPC

Sinus symptom/complaint

1.9

14.8

184

991

WW200

NOMESCO Finland

Immunization

3.0

14.8

226

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

14.8

112

499

S01BC03

ATC

diclofenac; ophthalmic

3.4

14.8

154

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

14.8

287

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

14.8

136

657

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

5.1

14.8

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.5

14.8

406

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

14.8

183

986

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.8

14.7

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

18.5

14.7

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.6

14.7

131

RF420, ,

NOMESCO Finland

5.3

14.7

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

5.3

14.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

14.6

176

939

4AB0M, ,

NOMESCO Finland

+∞

14.6

R05

ICPC

Cough

1.6

14.6

464

3239

J45

ICD-10 Finland

Asthma

1.9

14.5

205

1152

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

14.5

403

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.5

14.4

386

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

3.0

14.4

219

R03BA01

ATC

beclometasone; inhalant

1.8

14.4

239

1412

SPAT1312

SPAT

General health counselling

1.5

14.4

581

4266

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

14.3

156

803

TAB00

NOMESCO Finland

Lumbar puncture

2.5

14.3

369

J35.0

ICD-10 Finland

Chronic tonsillitis

2.1

14.2

136

667

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

14.2

104

457

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

14.2

534

3862

SDA03

NOMESCO Finland

Periodontal treatment

1.4

14.2

879

7004

R13

ICD-10 Finland

Dysphagia

2.2

14.1

114

523

R03AC12

ATC

salmeterol; inhalant

2.8

14.1

255

L40.8

ICD-10 Finland

Other psoriasis

6.7

14.0

J46

ICD-10 Finland

Status asthmaticus

3.2

14.0

175

M16.7

ICD-10 Finland

Other secondary coxarthrosis

5.9

14.0

SBB10

NOMESCO Finland

Dental impressions

2.1

13.9

140

700

J05AB01

ATC

aciclovir; systemic

1.6

13.9

427

2954

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

13.9

252

1527

OAB25, ,

SPAT

6.1

13.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

13.9

901

7231

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

13.7

136

676

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

13.7

174

944

R07.0

ICD-10 Finland

Pain in throat

1.9

13.7

167

894

A46

ICD-10 Finland

Erysipelas

1.8

13.7

215

1248

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

13.7

574

4239

M01AX05

ATC

glucosamine; oral

1.8

13.7

221

1295

XA800

NOMESCO Finland

Neuropsychological investigation

2.5

13.6

372

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

5.0

13.6

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

+∞

13.6

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

13.6

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

13.6

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

4.7

13.5

A07EA02

ATC

hydrocortisone; rectal

3.2

13.5

174

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

10.1

13.5

M46.2

ICD-10 Finland

Osteomyelitis of vertebra

140.9

13.5

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.4

13.4

399

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

5.1

13.4

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

5.6

13.4

M02.3

ICD-10 Finland

Reiter disease

21.3

13.3

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

13.3

292

R03BA08

ATC

ciclesonide; inhalant

1.9

13.2

169

919

298, ,

Kela drug reimbursment

10.5

13.2

SPAT1058

SPAT

PEF monitoring instruction

2.1

13.2

124

604

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

13.2

108

498

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.7

13.2

112

SPAT1097

SPAT

Recording of ECG

1.8

13.1

199

1144

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.5

13.1

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.5

13.1

RF410, ,

NOMESCO Finland

5.5

13.1

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

13.1

212

1243

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

13.0

511

3717

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

13.0

155

823

S06.0

ICD-10 Finland

Concussion

1.8

13.0

192

1095

NA3BG, ,

SPAT

2.5

12.9

326

D06

ICPC

Abdominal pain localized other

1.9

12.9

173

956

J01MA12

ATC

levofloxacin; systemic

1.7

12.9

278

1763

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

12.9

182

1023

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.7

12.9

262

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

12.8

429

3017

SPAT1131

SPAT

Colonoscopy

3.1

12.8

174

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

12.8

158

849

J05AB11

ATC

valaciclovir; oral

1.7

12.8

276

1751

R83

ICPC

Respiratory infection other

1.5

12.7

606

4576

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.2

12.7

WX320

NOMESCO Finland

Spinalanesthesy

1.5

12.7

405

2819

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.1

12.7

123

607

K08.80

ICD-10 Finland

Toothache NOS

1.8

12.6

202

1179

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

70.3

12.6

M65.3

ICD-10 Finland

Trigger finger

2.3

12.6

411

OAA65, ,

SPAT

1.5

12.5

497

3620

OAB47, ,

SPAT

2.0

12.5

145

763

M46.5

ICD-10 Finland

Other infective spondylopathies

+∞

12.5

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

12.5

592

4464

3029

Kela drug reimbursment

Upadacitinib

9.4

12.5

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.5

12.4

308

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

12.4

388

1220

FHL

Arthroscopy

2.8

12.4

227

P06

ICPC

Sleep disturbance

1.7

12.4

260

1637

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

12.4

250

OAB93, ,

SPAT

1.8

12.4

177

999

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

12.3

134

690

N07CA01

ATC

betahistine; oral

2.2

12.3

109

520

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.5

12.3

118

N05CF02

ATC

zolpidem; oral

1.6

12.2

309

2038

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.9

12.2

201

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

37.8

12.2

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.3

12.2

138

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

12.2

161

886

J01MA14

ATC

moxifloxacin; systemic

1.9

12.2

147

785

GX2D5

NOMESCO Finland

Sleep oximetry

5.5

12.1

R52.1

ICD-10 Finland

Chronic intractable pain

12.5

12.1

K80

ICPC

Cardiac arrhythmia NOS

2.0

12.1

142

751

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

8.7

12.0

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

12.0

160

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

12.0

126

641

M05BX04

ATC

denosumab; parenteral

2.4

12.0

363

M25.4

ICD-10 Finland

Effusion of joint

3.9

11.9

NA3CG, ,

SPAT

4.4

11.9

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

11.9

1140

9682

A04

ICPC

Weakness/tiredness general

1.6

11.9

273

1758

M48.9

ICD-10 Finland

Spondylopathy, unspecified

46.9

11.9

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

11.9

195

1147

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

11.9

207

1239

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

11.9

173

982

R60.0

ICD-10 Finland

Localized oedema

1.8

11.8

176

1005

C08CA13

ATC

lercanidipine; oral

1.8

11.8

196

1157

D07AC13

ATC

mometasone; topical

1.5

11.8

531

3959

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

10.6

11.8

J01FA01

ATC

erythromycin; systemic

1.6

11.7

293

1927

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.0

11.7

121

612

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

11.7

251

1589

M04AA01

ATC

allopurinol; systemic

1.9

11.6

150

819

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

65.3

11.6

C08DA01

ATC

verapamil; systemic

2.6

11.6

247

NBG10

NOMESCO Finland

Acromioplastia

3.9

11.6

SPAT1081

SPAT

Cardiorespiratory global assessment

2.5

11.5

295

M76.0

ICD-10 Finland

Gluteal tendinitis

3.7

11.5

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

11.5

361

2500

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

11.5

503

3727

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

11.5

326

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

11.5

426

3055

M05BA06

ATC

ibandronic acid; systemic

4.0

11.5

E000006, ,

ATC

2.1

11.5

115

575

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

11.5

R03BB01

ATC

ipratropium bromide; inhalant

3.1

11.5

154

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

120.7

11.4

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

11.4

409

S21

ICPC

Skin texture symptom/complaint

1.6

11.4

248

1576

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.2

11.4

423

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

11.3

173

996

Z2446

NOMESCO Finland

Social worker

2.0

11.3

117

592

K51.8

ICD-10 Finland

Other ulcerative colitis

3.5

11.3

110

L34

ICPC

Musculoskeletal, Blood test

35.2

11.3

L04AF03

ATC

upadacitinib; oral

8.9

11.3

G44.8

ICD-10 Finland

Other specified headache syndromes

3.3

11.2

125

KMAK, ,

NOMESCO Finland

1.4

11.2

1055

8900

D94

ICPC

Chronic enteritis/ulcerative colitis

4.8

11.2

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

11.2

250

1599

A03FA02

ATC

cisapride; oral, rectal

2.1

11.2

100

479

TQW80

NOMESCO Finland

Local dermatologic skincare

2.9

11.2

178

RF210, ,

NOMESCO Finland

2.9

11.2

178

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

11.1

128

672

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.7

11.1

223

NA1BG, ,

SPAT

3.2

11.1

136

R03BA05

ATC

fluticasone; inhalant

1.5

11.0

329

2251

WX780

NOMESCO Finland

Remote monitoring CPAP

2.2

11.0

448

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.6

11.0

236

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

10.9

230

1448

R49.01

ICD-10 Finland

Functional dysphonia

2.6

10.9

231

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

43.5

10.9

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.9

540

4091

SPAT1284

SPAT

Extensive health certificate

2.8

10.9

203

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

10.9

451

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.5

10.9

108

RS221, ,

NOMESCO Finland

3.9

10.8

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

10.8

209

1286

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

10.8

185

1101

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.0

10.8

165

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.8

10.8

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

4.9

10.7

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

17.9

10.7

J01FA15

ATC

telithromycin; oral

1.7

10.7

182

1081

C10AA03

ATC

pravastatin; oral

2.3

10.7

375

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.9

10.7

126

668

W19

ICD-10 Finland

Unspecified fall

1.8

10.7

152

857

C09CA01

ATC

losartan; oral

1.5

10.6

363

2556

M22.4

ICD-10 Finland

Chondromalacia patellae

2.5

10.6

270

M09AX01

ATC

hyaluronic acid; parenteral

2.8

10.6

183

H01

ICPC

Ear pain/earache

1.6

10.6

228

1443

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

10.6

709

5648

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

10.6

108

544

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

10.6

172

1009

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.2

10.6

436

M01AE51

ATC

ibuprofen, combinations; systemic

5.0

10.5

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

5.0

10.5

S01

ICPC

Pain/tenderness of skin

2.3

10.5

353

WX204

NOMESCO Finland

Axillary plexus blockaced

2.5

10.5

266

-1, ,

NOMESCO Finland

1.4

10.5

654

5150

SPAT1254

SPAT

Administration of medicine

1.7

10.4

204

1259

R4110, ,

SPAT

1.7

10.4

200

1228

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.8

10.4

167

975

M03.2*A04.6

ICD-10 Finland

Postinfectious arthropathy in enteritis due to Yersinia enterocolitica

+∞

10.4

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

+∞

10.4

N01

ICPC

Headache

1.6

10.4

225

1426

L11

ICPC

Wrist symptom/complaint

1.7

10.4

184

1106

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

10.4

255

U07

ICPC

Urine symptom/complaint other

1.9

10.4

127

682

D02

ICPC

Abdominal pain epigastric

2.0

10.4

115

597

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

10.3

480

D07AB08

ATC

desonide; topical

1.7

10.3

198

1217

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

10.3

173

1025

71599

ICD-8 Finland

Arthritis, unspecified

18.9

10.3

P01

ICPC

Feeling anxious/nervous/tense

1.6

10.2

290

1960

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

10.2

182

1095

R03AC13

ATC

formoterol; inhalant

2.3

10.2

363

L92

ICPC

Shoulder syndrome

3.1

10.2

138

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

10.2

325

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

10.2

357

EC1VA, ,

NOMESCO Finland

2.1

10.2

449

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.9

10.2

136

751

SFA00

NOMESCO Finland

Small restoration

1.6

10.2

267

1773

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

10.2

612

4785

J45.8

ICD-10 Finland

Mixed asthma

2.7

10.2

199

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.9

10.1

J01EA01

ATC

trimethoprim; systemic

1.5

10.1

424

3108

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

10.1

128

695

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.3

10.1

333

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

10.1

102

512

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

10.1

181

1092

R05

ICD-10 Finland

Cough

1.5

10.0

382

2748

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

10.0

334

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

10.0

432

NH3CG

NOMESCO Finland

Extensive MRI of foot

4.8

10.0

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.8

10.0

S97

ICPC

Chronic ulcer skin

2.2

10.0

373

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

14.6

10.0

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.8

10.0

178

SPAT1240

SPAT

Therapeutic discussion

1.6

10.0

214

1353

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.5

10.0

254

C08CA05

ATC

nifedipine; systemic

2.2

9.9

361

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

9.9

101

509

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.1

9.9

441

A02BB01

ATC

misoprostol; oral

16.8

9.9

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

16.8

9.9

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

16.8

9.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

9.8

138

774

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

12.2

9.8

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

9.8

220

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

26.1

9.8

B01AB04

ATC

dalteparin; parenteral

2.2

9.8

396

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

9.8

361

2580

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

8.8

9.8

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

4.7

9.8

J01DA09

ATC

[U] cefadroxil

1.4

9.8

483

3647

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.5

9.8

VALMI, ,

NOMESCO Finland

1.4

9.7

482

3639

WVA20, ,

SPAT

2.4

9.7

263

-1, ,

ICPC

2.5

9.7

257

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.2

9.7

391

WVA30, ,

SPAT

1.9

9.7

113

597

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

9.7

112

590

RT272, ,

NOMESCO Finland

13.4

9.7

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

55.2

9.6

QXB99, ,

SPAT

2.7

9.6

193

WX723

NOMESCO Finland

CPAP therapy

2.1

9.6

419

M01AB16

ATC

aceclofenac; oral

2.7

9.6

182

M01AC02

ATC

tenoxicam; systemic, rectal

2.5

9.6

253

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.5

9.6

253

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

4.5

9.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

9.5

374

S22.3

ICD-10 Finland

Fracture of rib

1.9

9.5

112

594

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

9.5

140

798

R75

ICPC

Sinusitis acute/chronic

2.0

9.5

102

524

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.2

9.5

118

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

9.5

588

4612

M05BA07

ATC

risedronic acid; oral

3.2

9.5

113

A02BC04

ATC

rabeprazole; oral

1.7

9.4

157

927

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

100.5

9.4

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

100.5

9.4

4AA12, ,

NOMESCO Finland

7.6

9.4

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

30.2

9.4

N05AH04

ATC

quetiapine; oral

1.5

9.4

316

2215

N06AX12

ATC

bupropion; oral

1.7

9.4

162

967

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

21.8

9.3

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.7

9.3

179

ZX114

NOMESCO Finland

Intramuscular

3.4

9.3

L04

ICPC

Chest symptom/complaint

1.9

9.3

111

591

RS222, ,

NOMESCO Finland

4.5

9.3

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

9.3

287

1976

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

10.7

9.3

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.7

9.2

180

N06AX03

ATC

mianserin; oral

2.3

9.2

314

S04

ICPC

Lump/swelling localized

1.6

9.2

205

1309

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.9

9.2

147

SPAT1377

SPAT

Polysomnography

2.4

9.2

258

S80.0

ICD-10 Finland

Contusion of knee

1.8

9.2

147

859

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.5

9.2

240

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

9.1

102

531

L04AC07

ATC

tocilizumab; parenteral

7.8

9.1

M53.8

ICD-10 Finland

Other specified dorsopathies

7.8

9.1

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

4.3

9.1

SPAT1216

SPAT

Assessment of functional ability

1.7

9.1

173

1060

J01

ICD-10 Finland

Acute sinusitis

1.8

9.1

125

697

EBA00

NOMESCO Finland

Extraction of tooth

1.4

9.1

682

5503

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.1

9.1

121

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.2

9.1

342

S01XA18

ATC

ciclosporin; ophthalmic

4.4

9.1

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.4

9.1

G03DB01

ATC

dydrogesterone; oral

1.5

9.1

257

1736

E000001, ,

ATC

1.5

9.1

357

2581

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

9.1

682

5506

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

11.5

9.1

G50.1

ICD-10 Finland

Atypical facial pain

3.4

9.0

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

15.6

9.0

RK220, ,

NOMESCO Finland

9.1

9.0

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

9.1

9.0

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

36.8

9.0

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.2

9.0

337

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

4.1

9.0

U05

ICPC

Urination problems other

2.3

9.0

305

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

9.0

129

730

E66.8

ICD-10 Finland

Other obesity

1.9

9.0

116

635

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

9.0

XKC03

NOMESCO Finland

Water cystometry

2.8

8.9

155

Z2445

NOMESCO Finland

Psychologist

2.2

8.9

358

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.4

8.9

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

24.1

8.9

N41.0

ICD-10 Finland

Acute prostatitis

3.3

8.9

102

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.7

8.9

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

8.9

412

R01AD01

ATC

beclometasone; nasal

1.5

8.9

278

1919

SPAT1283

SPAT

Restricted health certificate

1.4

8.9

387

2852

N03AX09

ATC

lamotrigine; oral

2.0

8.8

502

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

8.8

131

748

H26.4

ICD-10 Finland

After-cataract

1.9

8.8

106

566

EMB10

NOMESCO Finland

Tonsillectomy

1.8

8.8

129

734

R06AE09

ATC

levocetirizine; oral

1.5

8.8

288

2007

H81.0

ICD-10 Finland

Ménière disease

3.1

8.7

119

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

50.2

8.7

WZA00

NOMESCO Finland

Concise certificate

1.8

8.7

127

723

M23.8

ICD-10 Finland

Other internal derangements of knee

2.2

8.7

349

N06AX26

ATC

vortioxetine; oral

1.7

8.6

156

943

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.2

8.6

104

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

8.6

123

694

R35

ICD-10 Finland

Polyuria

2.0

8.6

444

R01AD11

ATC

triamcinolone; nasal

1.7

8.6

156

944

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.8

8.6

K07.68

ICD-10 Finland

Other disorders of the jaw joint

4.8

8.6

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.6

8.6

193

M77.4

ICD-10 Finland

Metatarsalgia

1.8

8.6

122

688

M53.9

ICD-10 Finland

Dorsopathy, unspecified

8.2

8.6

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

8.6

175

1093

R99

ICPC

Respiratory disease other

3.1

8.6

115

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

16.3

8.5

N06AB10

ATC

escitalopram; oral

1.4

8.5

404

3019

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

10.1

8.5

-50

ICPC

Medication/prescr/renewal

2.3

8.5

261

H92.0

ICD-10 Finland

Otalgia

1.8

8.5

127

727

R25.2

ICD-10 Finland

Cramp and spasm

2.9

8.5

137

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

8.5

167

1033

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

8.5

517

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

20.1

8.5

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.9

8.5

109

596

R11

ICD-10 Finland

Nausea and vomiting

1.7

8.5

140

826

N05CD07

ATC

temazepam; oral

1.8

8.4

131

760

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.1

8.4

106

H02AB09

ATC

hydrocortisone; systemic

2.7

8.4

172

EGA00

NOMESCO Finland

Arthroscopy of mandibular joint

12.8

8.4

SPAT1370

SPAT

Other health check-up

2.2

8.4

295

A11

ICPC

Chest pain NOS

1.8

8.3

122

694

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.8

8.3

144

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

8.3

239

1618

K59.0

ICD-10 Finland

Constipation

2.1

8.3

388

0381A

ICD-9 Finland

Septicaemia, Staphylococcal septicaemia[SEPTICHAEMIA STAPHYLOCOCCUS AUREUS]

+∞

8.3

4AB0X, ,

NOMESCO Finland

+∞

8.3

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

8.3

NA6AG, ,

NOMESCO Finland

+∞

8.3

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.7

8.3

161

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

8.3

121

687

R31

ICD-10 Finland

Unspecified haematuria

1.8

8.3

120

680

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

8.3

157

961

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

8.3

264

H15.0

ICD-10 Finland

Scleritis

8.6

8.3

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

8.3

451

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

8.2

330

2391

J01DA06

ATC

[U] cefuroxime

1.5

8.2

249

1705

RD210, ,

NOMESCO Finland

3.2

8.2

102

WW200, ,

SPAT

1.4

8.2

508

3968

G44.0

ICD-10 Finland

Cluster headache syndrome

3.4

8.2

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.4

8.2

K29.7

ICD-10 Finland

Gastritis, unspecified

2.4

8.2

234

FP4B5, ,

SPAT

4.2

8.2

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

8.2

155

949

SPAT1104

SPAT

Monitoring of emergency patient

2.0

8.2

474

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

8.2

118

669

N05BB01

ATC

hydroxyzine; systemic

1.8

8.2

115

647

A02BA03

ATC

famotidine; systemic

2.6

8.1

169

Z2221

NOMESCO Finland

Medical doctor

1.4

8.1

481

3731

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

8.1

518

C03AA03

ATC

hydrochlorothiazide; oral

1.9

8.1

511

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

33.5

8.1

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

17.2

8.1

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

11.7

8.1

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

8.1

240

1638

R06.5

ICD-10 Finland

Mouth breathing

1.7

8.1

161

1000

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

8.9

8.0

D11

ICPC

Diarrhoea

1.5

8.0

233

1583

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.2

8.0

314

205

Kela drug reimbursment

Chronic hypertension

1.5

8.0

271

1901

M10.9

ICD-10 Finland

Gout, unspecified

2.0

8.0

388

A01AB04

ATC

amphotericin B; local oral

2.3

7.9

257

SPAT1262

SPAT

Handing over of treatment supplies

1.5

7.9

238

1630

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

7.9

231

1572

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

7.9

688

5654

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

7.9

404

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

7.8

299

2146

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

7.8

120

694

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

7.8

100

547

SPAT1210

SPAT

Application of cast or individual aid

2.2

7.8

311

WX704

NOMESCO Finland

Intubation

1.7

7.8

130

770

WZB00, ,

SPAT

1.6

7.8

181

1169

AN1

Coronary angiography

1.9

7.7

526

A02BA04

ATC

nizatidine; systemic

2.0

7.7

455

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

7.7

441

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

7.7

145

886

N02CC04

ATC

rizatriptan; oral

1.8

7.7

122

711

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.4

7.7

216

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

7.7

332

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

7.7

137

826

B01AB10

ATC

tinzaparin; parenteral

1.6

7.7

170

1084

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

7.6

450

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

7.6

422

3233

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

7.6

130

774

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

7.6

141

859

RT271, ,

NOMESCO Finland

18.4

7.6

S01EC04

ATC

brinzolamide; ophthalmic

2.5

7.6

193

L30.3

ICD-10 Finland

Infective dermatitis

2.1

7.6

314

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006315) Basophils [#/volume] in Blood

1803

8825

7.79

318.15

12.7

6.4

0.04

e9/l

2.40

1711

7686

(3001604) Monocytes [#/volume] in Blood

1802

8818

7.78

317.98

12.6

6.4

0.56

0.55

e9/l

1.19

1710

7684

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

508

580

11.19

307.65

1.5

1.6

0.11

0.61

iu/ml

0.77

110

(3008898) HLA-B27 [Presence]

450

614

9.02

307.65

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

1812

9054

7.71

307.61

12.8

6.4

2.05

1.94

e9/l

3.08

1743

8079

(3013115) Eosinophils [#/volume] in Blood

1818

9129

7.77

306.31

12.8

6.6

0.18

e9/l

1.07

1745

8082

(3013650) Neutrophils [#/volume] in Blood by Automated count

1828

9917

6.95

260.58

14.8

10.1

3.91

3.97

e9/l

0.65

1735

8661

(3037522) Nuclear Ab [Titer] in Serum

820

2537

4.63

243.29

1.6

1.4

400.80

534.27

titre

1.74

199

524

(3019069) Monocytes/Leukocytes in Blood

1593

8151

4.79

232.15

13.0

6.6

8.59

8.61

0.15

1559

7719

(3006504) Eosinophils/Leukocytes in Blood

1584

8133

4.70

228.08

12.9

6.4

2.67

2.80

1.58

1550

7698

(3022096) Basophils/Leukocytes in Blood

1576

8131

4.61

223.58

13.1

6.5

0.73

0.69

2.62

1541

7677

(3002030) Lymphocytes/Leukocytes in Blood

1599

8458

4.57

215.89

12.9

6.4

30.60

28.80

11.10

1569

8089

(3018010) Neutrophils/Leukocytes in Blood

1579

8308

4.48

213.99

12.5

6.3

55.58

56.66

3.88

1556

8001

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1997

12644

10.28

213.48

11.3

3.7

11.60

10.34

mm/h

4.39

1961

11909

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

146

24.81

204.57

1.6

2.4

9.28

10.37

mg/l

0.80

112

(3035350) Ketones [Presence] in Urine by Test strip

1617

9048

4.27

190.84

5.7

3.2

0.00

5.78

estimate

2.07

430

1880

(3021601) Nitrite [Presence] in Urine by Test strip

1608

8966

4.24

190.69

5.7

3.2

0.00

estimate

0.34

430

1869

(3023420) DNA double strand Ab [Units/volume] in Serum

374

728

6.02

188.47

1.7

2.1

7.04

8.06

iu/ml

0.22

161

(3009261) Glucose [Presence] in Urine by Test strip

1618

9106

4.23

188.12

5.8

3.2

0.01

0.18

estimate

0.51

413

1773

(40760892) CBC W Ordered Manual Differential panel - Blood

1034

4370

3.65

187.37

8.1

4.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1944

12796

6.95

176.60

12.6

7.7

72.92

76.87

u/l

5.70

1912

12189

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

790

2950

3.67

170.45

1.4

1.3

8.27

11.63

u/ml

0.74

342

1251

(3015736) pH of Urine

1347

7175

3.39

159.95

4.8

2.9

6.23

6.18

1.17

718

4158

(3035933) Granulocytes/Leukocytes in Blood

238

369

7.14

149.23

3.9

3.2

56.68

57.71

0.63

238

369

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

796

3260

3.30

144.20

1.4

1.3

29.39

28.21

iu/ml

0.06

257

978

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1255

6913

2.98

130.92

5.7

3.0

0.01

0.10

estimate

0.71

390

1533

(3017181) Myelocytes/Leukocytes in Blood

471

1468

3.84

129.38

6.2

4.8

0.50

1.04

4.21

116

406

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

105

17.48

126.90

2.7

3.3

6.86

9.99

mg/l

2.45

(3025159) Blasts/Leukocytes in Blood

457

1429

3.80

124.58

6.7

5.1

0.01

0.38

0.90

100

330

(3002179) Metamyelocytes/Leukocytes in Blood

452

1404

3.82

124.41

5.6

4.6

0.37

0.68

1.86

106

393

(3021440) Promyelocytes/Leukocytes in Blood

453

1416

3.79

123.47

6.4

4.9

0.06

0.13

1.12

355

(3029937) Albumin [Presence] in Urine by Test strip

959

4689

2.90

122.88

6.4

3.3

0.00

0.01

estimate

1.54

417

1761

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

210

354

6.47

120.98

1.6

1.4

—

(3021589) Normoblasts [#/volume] in Blood

1343

7895

2.90

120.12

17.7

10.1

0.00

e9/l

0.23

1190

6467

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

18.57

119.61

2.4

52.21

121.45

au/ml

0.51

(3015171) Extractable nuclear Ab [Units/volume] in Serum

285

676

4.71

112.25

1.4

1.2

1.57

0.90

u/ml

0.31

(3017732) Neutrophils [#/volume] in Blood

562

2167

3.16

108.48

3.3

3.97

4.43

e9/l

1.26

529

1945

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

57.06

108.01

1.6

—

(3019150) Specific gravity of Urine by Refractometry

791

3739

2.77

104.55

5.9

3.2

1.02

1.43

kg/l

0.50

520

2419

(3048689) Calprotectin [Mass/mass] in Stool

590

2411

3.00

102.14

3.2

2.6

114.67

112.11

ug/g

0.09

492

1971

(3000475) Leukocytes [#/volume] in Synovial fluid

186

330

6.08

101.44

1.9

1.6

10788.96

16072.48

e6/l

0.60

137

228

(3018095) Leukocytes [#/volume] in Urine

1051

5868

2.56

97.16

4.4

3.4

51.49

95.63

e6/l

1.81

754

3871

(3017143) Hepatitis C virus Ab [Presence] in Serum

605

2572

2.89

96.77

1.5

1.6

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

116

133

9.17

93.39

1.8

1.7

57.63

58.38

0.06

(3000850) Epithelial cells [#/volume] in Urine

690

3195

2.72

93.12

2.8

2.5

4.78

7.15

e6/l

4.30

636

2880

(40758558) Short blood count panel - Blood

934

5080

2.49

89.33

7.6

6.3

—

(3018418) pH of Serum or Plasma

835

4344

2.52

87.54

3.8

4.1

7.40

0.99

561

3054

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1256

7958

2.41

83.45

3.1

2.3

76.60

75.05

nmol/l

1.27

1199

7426

(3044941) Cell count panel - Synovial fluid

143

241

6.29

81.91

1.7

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

448

1758

2.96

81.57

1.4

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

105

9.63

81.49

1.7

1.5

40.87

35.23

0.51

(40761535) Cells panel - Urine sediment

304

946

3.58

81.43

5.7

3.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

376

1337

3.20

81.31

2.9

10.63

10.75

g/l

0.22

348

1244

(3024561) Albumin [Mass/volume] in Serum or Plasma

1119

6838

2.34

79.45

4.9

5.0

36.80

36.51

g/l

1.08

1071

6465

(3002582) Erythrocytes [#/volume] in Urine

867

4832

2.34

75.32

3.4

2.9

86.90

88.29

e6/l

0.01

720

3543

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1168

7436

2.26

73.01

6.3

6.8

1.22

1.21

mmol/l

0.74

998

6453

(3041096) Erythrocytes [Presence] in Urine by Automated

911

5293

2.26

70.51

4.5

2.7

0.01

0.24

estimate

0.73

390

1471

(3030467) Casts [#/volume] in Urine by Automated count

758

4144

2.29

67.26

3.1

2.8

0.22

0.40

e6/l

3.56

600

2900

(3026493) Urate [Moles/volume] in Serum or Plasma

759

4186

2.26

65.62

2.3

2.4

312.75

329.07

umol/l

5.17

674

3838

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1041

6546

2.15

64.35

5.8

6.2

1.21

mmol/l

0.06

993

6100

(3014051) Protein [Presence] in Urine by Test strip

873

5176

2.16

62.26

3.5

2.6

0.00

0.02

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2078

17945

7.47

61.03

25.1

11.9

15.32

22.48

mg/l

38.50

1915

14227

(3034891) Synovial lining cells/cells in Synovial fluid

12.05

60.26

1.6

1.4

4.23

1.30

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

755

4293

2.18

59.28

2.4

2.0

143.21

261.12

u/l

2.31

721

4079

(3028026) IgM [Mass/volume] in Serum or Plasma

290

1057

3.02

59.06

1.8

2.0

1.32

1.50

g/l

0.82

277

989

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

717

4035

2.17

57.45

2.7

2.2

2.71

2.69

mg/l

0.09

640

3497

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

700

3917

2.17

56.78

1.6

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

824

4960

2.08

54.74

2.7

2.5

56.87

62.96

u/l

1.06

763

4630

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1892

15733

2.81

51.62

26.7

15.1

13.64

13.41

13.46

1882

15517

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1197

8398

1.97

50.03

5.6

6.6

9.79

11.17

umol/l

2.84

1135

8034

(3031040) Bacteria [#/volume] in Urine by Automated count

1441

10848

2.02

48.27

5.0

3.7

640.07

1987.57

e6/l

0.80

130

(3022948) Iron [Moles/volume] in Serum or Plasma

497

2569

2.22

48.03

2.5

2.4

13.21

14.09

umol/l

1.85

467

2412

(4034850) Laboratory test

161

469

3.63

46.93

8.5

6.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

9.40

46.69

1.2

1.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1281

9320

1.94

46.68

3.7

3.0

108.05

99.98

ug/l

0.56

1219

8857

(3030981) Hyaline casts [#/volume] in Urine by Automated count

273

1103

2.69

45.34

2.5

2.3

0.24

0.53

e6/l

1.59

237

1045

(3007164) IgA [Mass/volume] in Serum or Plasma

669

3947

2.01

45.16

1.6

1.5

2.42

2.29

g/l

1.22

483

2636

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

172

537

3.40

45.04

1.2

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

284

1186

2.61

44.08

2.4

2.3

19.23

19.64

au/ml

0.04

177

(3004789) Transferrin [Mass/volume] in Serum or Plasma

454

2364

2.17

42.51

2.5

2.4

2.41

2.38

g/l

0.47

424

2205

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

204

731

2.98

42.34

1.3

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

264

1092

2.62

41.68

1.3

41.75

50.30

au/ml

0.32

(3026782) Osmolality of Urine

511

2830

2.06

40.44

3.2

2.6

534.36

536.67

mosm/kgh2o

0.08

458

2459

(3021960) Folate [Moles/volume] in Serum or Plasma

653

3959

1.94

39.81

1.7

1.6

20.57

20.18

nmol/l

0.26

588

3433

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

416

2144

2.17

39.72

2.5

22.83

24.11

1.17

389

2013

(3022145) Colonoscopy Study observation

375

1875

2.21

38.53

1.5

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

461

2499

2.08

38.44

2.6

2.5

0.96

1.21

e6/l

0.48

294

1232

(3013826) Glucose [Moles/volume] in Serum or Plasma

1244

9304

1.81

37.91

4.8

4.6

6.36

6.56

mmol/l

3.26

1185

8689

(3010144) Erythrocytes [#/volume] in Synovial fluid

118

5.92

37.66

1.5

1.4

3440.39

71099.46

e6/l

1.50

(40761536) Microorganisms panel - Urine sediment

303

1411

2.34

36.79

4.9

3.3

—

(3042936) Bacteria identified in Isolate by Culture

408

2148

2.11

36.60

2.4

2.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

707

4504

1.85

36.34

1.4

1.3

1.31

1.67

u/ml

0.35

225

1321

(3004588) Protein electrophoresis panel - Serum or Plasma

202

782

2.75

36.20

2.1

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

330

1610

2.24

35.83

2.4

2.1

347.44

381.65

nmol/l

2.57

316

1515

(46235355) HIV 1 and 2 tests - Meaningful Use set

729

4712

1.83

35.60

1.9

2.0

—

(3032080) INR in Blood by Coagulation assay

924

6441

1.77

34.75

10.9

10.8

1.16

1.17

inr

0.33

783

5323

(3020630) Protein [Mass/volume] in Serum or Plasma

232

997

2.49

33.55

2.1

2.8

68.29

66.91

g/l

2.08

214

943

(3023368) Bacteria identified in Blood by Culture

604

3773

1.84

32.38

5.1

4.1

—

(4062490) Immunoglobulin typing, IgG

167

4.68

32.35

1.6

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

804

5474

1.75

32.16

2.9

3.5

2.35

mmol/l

0.52

766

5094

(3024263) Appearance of Synovial fluid

7.10

30.57

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

298

3.58

30.24

1.7

1.8

0.48

0.79

g/l

2.84

231

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

787

5401

1.73

30.10

3.8

2.9

115.91

43.51

ng/l

0.34

483

3070

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

222

988

2.39

29.63

1.8

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

171

4.45

29.60

1.6

1.4

3.00

3.01

g/l

0.02

121

(3024139) IgG subclass 3 [Mass/volume] in Serum

171

4.45

29.60

1.6

1.4

0.40

0.42

g/l

0.18

120

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

473

2807

1.88

29.46

2.5

2.8

2.43

mmol/l

0.08

432

2533

(3027135) IgG subclass 1 [Mass/volume] in Serum

172

4.42

29.38

1.6

1.4

6.32

6.91

g/l

0.61

121

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

586

3746

1.78

28.49

1.8

1.7

0.90

1.02

mg/l

0.57

453

2815

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1944

17380

2.36

28.22

19.0

11.3

90.87

88.07

ml/min/173m2

8.44

1877

15826

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2086

19347

4.79

28.16

24.1

10.1

26.91

26.59

u/l

0.39

2071

18891

(3019550) Sodium [Moles/volume] in Serum or Plasma

1977

17831

2.51

27.66

17.9

13.1

139.56

139.71

mmol/l

2.52

1954

17435

(3023103) Potassium [Moles/volume] in Serum or Plasma

1981

17891

2.53

27.49

17.9

13.2

3.93

3.94

mmol/l

1.04

1955

17448

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1689

14414

1.83

27.46

4.8

4.4

14.69

14.50

pmol/l

3.06

1593

13499

(3045414) Leukocytes [Presence] in Urine

275

1381

2.14

27.38

2.1

2.0

0.00

0.02

estimate

1.06

322

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

144

544

2.77

26.92

1.5

1.2

43.91

42.32

u/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

914

6671

1.65

26.83

2.2

1.9

96.32

97.44

pmol/l

0.32

523

3645

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

176

738

2.51

26.68

1.9

2.3

39.55

39.53

u/l

0.01

160

675

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

120

414

3.01

26.48

2.0

1.5

—

(3027945) Reticulocytes/Erythrocytes in Blood

287

1484

2.08

26.41

2.4

3.0

1.83

1.78

0.38

268

1348

(3026008) Bacteria identified in Urine by Culture

647

4344

1.70

25.99

3.3

2.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

120

423

2.95

25.49

1.5

1.2

41.21

36.49

u/ml

0.10

(3019309) Folate [Moles/volume] in Red Blood Cells

366

2087

1.91

25.42

1.8

1.6

1389.68

1135.30

nmol/l

5.69

287

1618

(3045424) Erythrocytes [Presence] in Urine

175

752

2.45

25.15

2.1

2.0

0.00

0.02

estimate

0.88

246

(40768797) Stomach Pathology biopsy report

373

2148

1.89

25.11

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

140

550

2.65

24.24

1.4

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

850

6214

1.61

24.00

3.6

3.2

32.07

31.87

u/l

0.04

805

5897

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

131

508

2.68

23.27

1.5

1.3

3.96

8.95

u/ml

0.84

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

130

506

2.67

22.92

1.4

1.2

2.28

3.56

u/ml

0.49

(3025941) Bacteria identified in Stool by Culture

206

988

2.20

22.90

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

491

3159

1.72

22.57

1.8

1.6

33100661.42

41880450.52

pmol/l

0.13

429

2734

(3023520) Reticulocytes [#/volume] in Blood

219

1085

2.14

22.42

2.1

3.0

73.31

72.11

e9/l

0.18

161

790

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

373

2229

1.82

22.09

1.9

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

135

548

2.56

21.87

1.3

79.33

86.46

titre

0.15

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

275

1514

1.94

20.98

1.8

—

(3000494) Fungus identified in Specimen by Culture

351

2095

1.81

20.77

1.5

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

224

1155

2.05

20.58

4.7

3.6

1.22

1.23

mmol/l

0.81

195

985

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

124

500

2.57

20.36

2.3

2.1

0.94

2.13

ug/l

1.03

114

452

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

162

3.85

20.33

1.3

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

423

2683

1.72

20.23

3.3

3.2

447.00

548.77

ng/l

0.16

259

1782

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

516

3454

1.65

20.12

2.8

3.0

986.17

1085.28

ng/l

0.19

444

2885

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

105

393

2.76

19.98

1.4

1.2

3.31

1.22

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

5.42

19.98

1.3

1.6

5.31

6.35

u/l

0.70

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

138

4.06

19.82

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

138

4.06

19.82

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1002

7835

1.53

19.81

2.9

2.6

—

estimate

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

628

4431

1.59

19.67

1.9

1.6

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

144

3.97

19.52

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

103

389

2.73

19.27

3.0

2.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

133

4.06

19.10

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

138

3.99

18.99

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1866

16912

1.83

18.74

5.7

5.1

1.67

1.82

mu/l

9.82

1785

15940

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

279

1602

1.85

18.61

2.5

4.9

231.36

241.94

u/l

0.58

265

1537

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

133

3.98

18.27

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

274

1587

1.83

17.74

1.8

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

308

1858

1.77

17.39

2.0

1.6

—

(3018333) Ribosomal P Ab [Presence] in Serum

129

3.95

17.37

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

260

1493

1.84

17.29

3.7

2.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

223

1225

1.92

17.01

2.6

2.2

70.70

73.16

ml/min/173m2

0.38

502

(3005322) IgE [Units/volume] in Serum or Plasma

229

1284

1.88

16.39

1.4

1.3

177.38

264.74

u/ml

0.47

218

1192

(3039162) Centromere protein B Ab [Units/volume] in Serum

210

3.11

15.47

1.6

1.3

9.47

78.47

u/ml

—

(40768443) Skin Pathology biopsy report

139

668

2.16

15.32

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

373

2.53

14.98

1.8

2.0

0.00

0.02

g/l

0.98

337

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

265

2.78

14.21

1.5

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

106

470

2.32

14.20

2.1

2.4

10.65

11.95

mg/l

0.79

101

445

(3012544) pH of Venous blood

227

1327

1.80

14.15

3.8

3.6

7.39

7.38

0.99

123

755

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

427

2.33

13.23

2.1

0.41

0.97

g/l

1.41

375

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

5.15

13.16

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

119

574

2.14

13.01

1.7

2.0

1.48

g/l

0.01

103

501

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

349

2337

1.59

13.00

2.9

2.6

3.32

3.29

e6/l

0.01

184

1063

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

261

2.70

12.95

1.2

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

5.63

12.89

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

354

2.43

12.64

1.4

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1532

13625

1.44

12.55

3.7

3.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

351

2.42

12.40

2.7

3.5

50.13

64.96

mg/l

0.29

293

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

360

2.39

12.19

1.9

2.0

0.00

g/l

-0.00

316

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.53

12.12

1.1

—

(3037756) Immunofixation for Serum or Plasma

242

2.70

12.04

1.4

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

267

2.60

11.88

1.3

—

57.50

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

352

2.38

11.86

2.6

3.5

25.13

75.40

mg/l

0.87

297

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

239

1489

1.68

11.84

7.1

9.0

5.04

5.09

kpa

0.41

234

1439

(3027801) Oxygen [Partial pressure] in Arterial blood

239

1489

1.68

11.84

7.1

9.0

12.39

13.15

kpa

1.57

234

1438

(3002032) Base excess in Venous blood by calculation

212

1281

1.73

11.75

4.0

3.6

1.97

1.73

mmol/l

0.50

186

1093

(3012095) Magnesium [Moles/volume] in Serum or Plasma

361

2493

1.54

11.66

2.7

3.7

0.81

0.82

mmol/l

0.59

343

2374

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

266

2.57

11.45

1.3

1.2

160.00

489.52

titre

0.96

(3003327) Ova and parasites identified in Stool by Light microscopy

133

705

1.95

11.26

1.7

1.6

—

(3019060) Gas panel - Arterial blood

132

698

1.95

11.25

5.3

5.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

128

673

1.96

11.10

2.5

2.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

284

1884

1.59

10.91

5.1

6.3

1.04

mmol/l

0.01

265

1772

(3019977) pH of Arterial blood

236

1497

1.65

10.89

7.2

9.0

7.42

0.77

133

814

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

366

2.29

10.88

1.3

1.2

3.60

3.65

mmol/l

0.18

349

(3026389) Candida sp identified in Specimen by Organism specific culture

226

2.66

10.85

1.6

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

325

2228

1.54

10.80

1.9

2.1

29.24

29.31

0.09

313

2165

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

440

2.16

10.72

1.2

1.3

—

(3003396) Base excess in Arterial blood by calculation

235

1495

1.64

10.71

7.1

8.9

1.09

0.91

mmol/l

0.35

199

1242

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

306

2.40

10.68

1.4

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

163

2.93

10.41

1.5

2.3

31.68

32.57

0.55

163

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

100

1899

0.50

10.41

3.6

4.2

33.69

31.79

0.76

1358

(3007461) Platelets [#/volume] in Blood

2094

20273

2.95

10.29

36.4

18.5

272.29

258.63

e9/l

18.29

2085

19916

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

351

2.27

10.17

1.4

1.5

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2094

20280

2.93

10.15

36.2

18.4

91.22

90.43

13.53

2089

20099

(3035941) MCH [Entitic mass]

2094

20281

2.92

10.13

36.1

18.4

30.28

30.18

2.16

2088

20099

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

283

2.41

10.09

1.3

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2094

20284

2.91

10.07

36.6

18.8

40.46

41.40

1.80

2088

20090

(3026361) Erythrocytes [#/volume] in Blood

2094

20285

2.91

10.04

36.3

18.4

4.48

4.55

e12/l

12.56

2085

19880

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

315

2.33

10.02

2.5

3.2

3.52

3.74

ratio

0.03

167

(3010813) Leukocytes [#/volume] in Blood

2094

20289

2.90

9.96

36.4

18.5

6.92

6.60

e9/l

7.72

2083

19874

(3000963) Hemoglobin [Mass/volume] in Blood

2094

20294

2.88

9.86

36.6

18.5

134.82

136.58

g/l

8.43

2089

20112

(3009508) Creatinine [Moles/volume] in Urine

670

5341

1.37

9.82

2.9

3.5

7.43

7.90

mmol/l

1.68

588

4668

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

373

2.19

9.59

1.4

1.5

328.17

846.06

e6/l

0.51

292

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

3.65

9.55

1.3

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

142

814

1.80

9.44

3.9

2.9

129.53

131.75

g/l

0.55

137

790

(3033658) Prothrombin time (PT) actual/Normal

531

4097

1.39

9.43

4.1

3.8

95.62

93.75

1.14

516

4020

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1792

16683

1.47

9.33

5.8

5.1

37.47

38.16

mmol/mol

3.13

1727

15888

(3012501) Base excess in Blood by calculation

281

2.35

9.32

2.5

3.5

2.60

2.45

mmol/l

0.18

179

(3000570) Elastase.pancreatic [Mass/mass] in Stool

415

2.09

9.08

1.5

1.4

278.38

292.06

ug/g

0.24

238

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

369

2.16

9.04

1.4

16.08

43.24

e6/l

0.67

275

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

281

1939

1.52

8.99

2.1

2.7

5.47

7.85

umol/l

2.89

239

1702

(3004809) Band form neutrophils/Leukocytes in Blood

219

2.50

8.90

3.3

3.2

1.29

1.47

0.11

204

(3009871) Measles virus Ab [Titer] in Serum

3.53

8.80

1.6

2834.29

1813.33

titre

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

108

3.18

8.78

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

108

3.18

8.78

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

283

2.30

8.74

1.1

6.32

3.24

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1821

17055

1.47

8.71

4.7

4.2

5.74

5.77

mmol/l

0.37

1720

15971

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

148

884

1.72

8.56

2.5

2.9

76.94

174.18

ng/l

6.69

139

789

(3023323) Follitropin [Units/volume] in Serum or Plasma

221

1470

1.56

8.34

1.4

23.70

27.04

iu/l

0.82

184

1263

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

425

2.02

8.19

1.3

501.51

517.94

mg/l

0.12

411

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

219

1467

1.55

8.01

2.5

2.3

0.22

g/l

0.04

205

1387

(37208534) Antinuclear antibody arbitrary concentration in serum

4.15

8.00

1.2

1.0

—

(3047181) Lactate [Moles/volume] in Blood

402

2.03

7.95

5.2

6.9

1.47

1.28

mmol/l

0.48

353

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

161

1006

1.65

7.88

3.5

4.0

85.05

83.66

ng/l

0.08

141

890

(36660697) Celiac disease serology panel - Serum

223

1515

1.53

7.65

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

386

2913

1.40

7.65

2.0

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

407

1.98

7.35

2.4

3.2

1.39

2.26

index

0.74

224

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

231

1595

1.50

7.34

1.8

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

191

2.44

7.27

1.3

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

460

1.91

7.18

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

585

4755

1.32

7.09

3.7

4.3

8.39

8.54

mg/mmol

0.03

354

3028

(3014765) Yersinia sp identified in Stool by Organism specific culture

456

1.90

7.04

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

400

1.96

7.01

1.4

1.7

—

(3012516) Albumin [Mass/volume] in Urine

574

4662

1.32

6.98

3.0

3.6

51.90

48.34

mg/l

0.13

355

2988

(3016650) Hepatitis A virus Ab [Presence] in Serum

353

2.02

6.93

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

103

2.94

6.86

1.2

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

883

7600

1.28

6.85

2.0

1.8

1.45

1.38

mmol/l

1.09

765

6605

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

455

1.88

6.77

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.23

6.70

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

174

2.44

6.70

1.3

1.4

0.32

0.27

nmol/l

0.12

139

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

408

1.92

6.64

1.4

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

239

2.21

6.56

1.3

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

196

1340

1.51

6.54

2.4

2.3

12.95

13.12

nmol/l

0.10

187

1251

(3023419) Bacteria identified in Sputum by Culture

159

2.48

6.44

1.5

3.0

—

(1616796) Gas panel - Central venous blood

296

2.06

6.34

2.3

3.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

173

2.40

6.30

1.4

—

nmol/l

—

(3000991) Gas panel - Venous blood

176

1192

1.52

6.14

7.2

9.5

—

(3000012) Reticulocyte production index

169

2.39

6.14

1.9

2.3

0.91

0.92

0.03

106

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

100

2.82

6.00

1.2

1.1

1.56

1.08

u/l

0.67

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

123

2.63

5.97

1.3

2.0

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1719

16182

1.32

5.97

28.9

15.1

331.77

332.80

g/l

5.27

1713

16076

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

408

3221

1.33

5.96

2.0

2.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

120

751

1.63

5.89

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

148

2.46

5.87

1.2

1.1

33.44

44.56

mg/l

0.99

120

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

142

928

1.57

5.83

2.2

2.0

9.93

8.19

ug/l

0.12

125

829

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

509

1.76

5.78

1.2

1.1

3.86

4.20

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

172

1180

1.50

5.66

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

275

2.03

5.64

1.4

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.82

5.57

1.2

1.1

2.87

4.78

nmol/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

325

1.93

5.57

1.2

7.88

3.36

u/ml

0.45

113

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

256

2.06

5.56

1.3

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

171

2.30

5.54

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

128

2.52

5.54

1.1

1.09

1.05

ratio

0.52

109

(3006442) Creatine [Moles/volume] in Serum or Plasma

117

2.59

5.47

1.7

1.2

74.03

75.44

umol/l

0.19

117

(3009214) Lutropin [Units/volume] in Serum or Plasma

108

672

1.64

5.45

1.3

1.4

13.51

9.89

u/l

1.38

546

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

349

1.89

5.44

1.4

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

308

1.94

5.37

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

431

1.79

5.36

1.1

1.2

243.93

270.36

u/ml

0.46

273

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

221

2973

0.71

5.29

1.9

3.46

3.49

ratio

0.14

170

2200

(3044640) Blood type and Crossmatch panel - Blood

631

5350

1.25

5.21

2.4

2.2

—

(40768804) Tissue Pathology biopsy report

832

7278

1.23

5.17

2.1

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

260

1958

1.37

5.15

2.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

459

1.75

5.15

1.9

2.3

262.49

471.22

ug/l

0.88

432

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

110

699

1.60

5.12

1.6

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

184

2.20

5.10

1.3

1.8

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

160

2264

0.68

5.10

1.6

1.7

3.57

3.52

mmol/l

0.20

107

1508

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

2.86

5.09

1.4

1.5

—

69.67

—

(3044290) Cell count panel - Cerebral spinal fluid

358

1.84

5.06

1.3

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

111

2.54

4.96

1.2

1.3

0.52

0.65

ratio

1.33

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

215

1582

1.40

4.90

1.3

1.2

68.52

139.65

u/ml

3.11

613

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

203

1479

1.41

4.90

7.5

5.2

—

(3022621) pH of Urine by Test strip

185

1326

1.43

4.89

3.4

2.1

6.08

6.09

0.08

131

819

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

531

1.67

4.77

1.1

4.58

5.70

eliau/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.92

4.60

1.1

1.0

0.18

1.61

u/ml

0.58

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

120

800

1.53

4.57

3.8

3.6

24.54

24.13

mmol/l

1.02

120

790

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

416

1.73

4.53

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

633

1.59

4.52

1.4

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

4.84

4.49

1.4

—

(3049717) Cytology report of Urine Cyto stain

395

1.75

4.48

2.4

2.5

—

(3017704) Immunofixation for Urine

3.02

4.40

1.8

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

7.53

4.35

1.0

1.1

—

titre

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

132

2.29

4.29

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

325

2605

1.29

4.19

1.7

1.8

1.49

1.38

1.47

285

2358

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

141

2.22

4.12

1.3

1.4

1.87

1.99

mmol/l

0.54

136

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

154

1103

1.43

4.12

1.9

2.2

1537.25

7185.10

u/l

4.36

464

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

230

1.93

4.07

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

110

2.38

4.07

1.2

2.0

0.64

1.97

u/field

1.72

(3026480) Teichoate Ab [Titer] in Serum

10.03

4.01

1.0

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

137

968

1.44

3.95

1.9

1.7

308.48

298.80

mu/l

0.11

126

869

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

206

1564

1.35

3.90

2.2

2.3

35.91

71.96

u/l

0.62

163

1352

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

151

1089

1.42

3.90

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

185

2.02

3.89

1.3

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

352

1.72

3.86

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.98

3.85

1.4

1.1

17.33

17.09

umol/l

0.06

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.49

3.80

1.3

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

114

2.30

3.78

3.4

3.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

106

719

1.50

3.77

1.6

1.7

7.80

13.40

u/ml

1.16

225

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

394

1.67

3.73

1.1

1.4

145.88

143.84

au/ml

0.05

109

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.70

3.66

2.4

3.5

22.44

21.31

ug/l

0.12

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

164

2.03

3.55

1.5

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

213

1.89

3.54

1.2

1.3

—

(3021901) Oxygen saturation in Capillary blood

271

1.79

3.54

2.4

2.8

91.07

90.87

0.09

263

(3042631) Mycobacterium sp identified in Specimen

171

2.00

3.54

2.2

2.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

105

2.30

3.52

1.7

2.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

340

1.70

3.49

1.9

2.1

131.98

132.21

g/l

0.03

275

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

112

2.25

3.48

1.1

1650.92

1399.18

miu/ml

0.56

112

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

125

2.17

3.48

1.5

1.2

11.37

9.48

mm/h

0.22

125

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.77

3.42

1.1

10.17

480.29

ng/l

—

(21494755) Public health laboratory ask at order entry panel

216

2736

0.77

3.42

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

173

1307

1.35

3.41

3.2

3.6

4.62

4.55

pmol/l

0.29

156

1190

(44813793) Dust mix specific IgE antibody measurement

133

2.12

3.40

1.1

—

(3012565) Volume of 24 hour Urine

2.40

3.39

1.2

2.5

2053.33

1863.37

0.36

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

190

0.26

3.39

31.4

20.0

1258.60

1448.51

nmol/l

—

185

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.84

3.36

1.1

2.0

2.21

1.46

ratio

0.80

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.72

3.32

1.4

1.6

347.60

111.50

umol/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.93

3.30

1.7

7.59

8.48

ug/l

0.44

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

362

1.65

3.27

1.2

1.1

12.65

14.58

au/ml

0.15

117

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.31

3.26

1.1

1.2

—

7.80

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

185

0.27

3.25

20.6

15.6

773.00

7818.45

nmol/l

—

179

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

156

2.00

3.25

1.2

1.3

0.03

1.34

u/ml

1.90

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

465

3995

1.21

3.20

2.5

2.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

319

1.68

3.17

2.5

2.9

8.39

8.37

kpa

0.04

311

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.30

3.10

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

202

1.85

3.08

1.7

1.4

62.48

63.97

mmol/l

0.07

168

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

123

895

1.40

3.08

1.3

283.73

232.11

miu/ml

0.76

446

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

132

2.06

3.07

1.3

1.2

314.00

262.22

titre

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

106

2.18

3.03

1.5

1.6

8.33

6.57

u/l

0.24

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.35

3.01

1.1

1.0

7.55

6.92

mg/g

0.08

(3011048) Pyruvate [Moles/volume] in Blood

10.02

2.98

1.4

1.2

68.00

57.00

umol/l

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

101

2.19

2.93

3.6

3.4

420.77

1042.20

u/ml

1.67

101

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

454

1.54

2.90

2.0

1.8

204.96

208.25

pmol/l

0.10

433

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

6.68

2.87

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.30

2.84

1.8

1.4

22.00

25.67

u/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

403

3454

1.21

2.83

4.6

4.4

2.04

2.06

ug/l

0.01

379

3150

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1437

13629

1.17

2.82

3.5

3.0

46.17

41.73

u/l

1.10

1371

13049

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1880

18262

1.25

2.81

4.9

4.4

4.74

4.78

mmol/l

1.05

1807

17442

(3020650) Glucose [Presence] in Urine

2.47

2.79

2.1

1.3

0.00

estimate

-0.00

(3014148) Varicella zoster virus Ab [Titer] in Serum

316

1.63

2.77

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

111

2.08

2.73

2.8

2.6

727.87

1360.77

1.53

111

(21494814) CD8 cells/Lymphocytes in Specimen

2.37

2.72

1.4

2.0

29.94

29.15

0.06

(44790048) Parainfluenza type 2 nucleic acid detection

211

1.77

2.71

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

211

1.77

2.71

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

211

1.77

2.71

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

211

1.77

2.71

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

322

2711

1.22

2.71

3.9

3.6

22.61

21.51

0.53

137

1084

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1893

18415

1.25

2.71

5.4

4.8

2.81

2.85

mmol/l

1.26

1811

17509

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.25

2.70

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.25

2.70

1.3

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

127

952

1.36

2.68

1.4

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.22

2.68

1.8

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.22

2.68

1.0

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

335

1.60

2.67

2.0

2.2

6.53

5.45

umol/l

0.28

252

(3044927) Protein electrophoresis panel - Urine

2.13

2.65

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.40

2.63

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

572

1.45

2.63

2.3

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

506

1.48

2.62

2.2

1.8

—

(3006462) Nitrate [Presence] in Urine

2.66

2.62

5.0

2.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

385

1.55

2.60

3.5

3.0

0.31

0.35

iu/ml

0.44

206

(3004716) Salmonella sp identified in Stool by Organism specific culture

136

1036

1.33

2.60

1.6

1.4

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

3.61

2.57

1.2

1.9

2.44

1.76

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

156

1.87

2.57

1.1

—

(3000330) Specific gravity of Urine by Test strip

696

1.40

2.50

4.3

2.9

1.02

ratio

1.31

616

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1109

0.70

2.50

1.1

0.53

0.63

ratio

—

119

(4198724) Urine methamphetamine measurement

2.12

2.49

2.8

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.98

2.48

1.1

1.0

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

342

1.56

2.47

2.9

2.5

13.27

13.08

0.55

337

(3043238) Trisomy 21 risk [Likelihood] in Fetus

726

0.64

2.42

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

228

1.68

2.37

1.2

1.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.42

2.37

1.1

1.5

87.66

575.57

nmol/24h

0.51

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

139

1.88

2.36

1.7

2.3

18.17

19.53

nmol/l

0.39

132

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

118

1.96

2.35

1.4

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

323

1.56

2.33

1.2

4.37

4.02

u/ml

0.10

140

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.05

2.31

1.3

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

147

1156

1.29

2.27

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1867

18195

1.21

2.24

4.7

4.4

1.49

1.48

mmol/l

0.12

1785

17286

(44806420) Estimation of glomerular filtration rate

263

1.61

2.24

2.9

2.3

—

(3013512) EKG study

552

4953

1.15

2.21

3.2

2.9

—

0.75

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

706

0.66

2.16

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

694

0.66

2.16

1.5

1.28

1.27

0.01

488

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

298

1.56

2.14

1.3

1.7

—

(4211845) Urine protein measurement

2.37

2.12

5.0

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

111

853

1.32

2.05

1.6

1.7

0.23

0.33

mg/l

1.32

402

(3016228) CD19 cells/cells in Blood

2.18

2.04

1.1

2.0

7.87

8.62

0.15

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

154

1.76

2.04

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

2.41

2.02

1.2

1.4

11.99

9.14

mmol/l

0.56

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

118

1.87

2.01

1.4

1.8

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.64

2.00

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1153

0.74

1.98

1.1

1.52

1.54

g/l

0.35

1153

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.29

1.97

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.34

1.96

3.4

5.9

10.39

10.91

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

179

1.69

1.95

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

157

1272

1.25

1.94

7.3

8.2

8.53

8.50

mmol/l

0.02

151

1222

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.97

1.93

13.5

5.1

5.75

5.17

kpa

—

(1761868) Lipid panel - Serum or Plasma

813

8732

0.89

1.92

3.0

2.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.06

1.91

1.3

1.8

2.10

5.69

u/field

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.25

1.91

1.0

1.5

104.00

92.30

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

434

3867

1.15

1.90

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.19

1.88

3.7

2.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.86

1.86

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

129

1.79

1.85

4.0

2.2

24.11

31.91

mg/l

0.49

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

129

1.79

1.85

1.3

163.62

158.85

pmol/l

0.08

129

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.21

1.84

1.0

1.2

99.13

91.03

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

335

2935

1.17

1.83

1.5

—

(3023410) Appearance of Cerebral spinal fluid

184

1.64

1.78

1.2

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

146

1.72

1.77

1.8

1.7

—

(3013637) Mi-2 Ab [Presence] in Serum

2.35

1.77

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.35

1.77

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.35

1.77

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.35

1.77

1.0

1.1

—

(1002224) Polysomnography panel

142

1151

1.25

1.77

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.67

1.72

1.4

1.1

1.19

1.20

mmol/l

—

(4024509) Urine culture

665

1.32

1.71

2.1

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.51

1.66

1.5

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

164

0.42

1.66

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.10

1.65

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

892

0.74

1.62

1.5

57.48

59.16

ug/l

0.15

733

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.15

1.61

2.4

3.6

0.96

1.43

0.54

(3000764) Benzodiazepines [Presence] in Urine

138

1129

1.24

1.60

1.9

2.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.70

1.58

1.1

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

191

1.58

1.57

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

818

0.74

1.56

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

827

0.74

1.53

1.4

1.5

0.97

0.96

ratio

0.09

493

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

827

0.74

1.53

1.4

1.5

1.12

1.18

ratio

0.23

495

(3036489) Thrombin time

695

1.29

1.53

1.7

1.8

19.92

20.53

0.50

606

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

826

0.74

1.52

1.4

1.5

1.17

1.12

ratio

0.17

492

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.60

1.51

2.4

2.9

—

(3037121) Protein [Mass/volume] in Urine

521

1.34

1.51

3.3

3.7

271.33

285.52

mg/l

0.07

236

(3015235) Bicarbonate [Moles/volume] in Capillary blood

452

1.36

1.50

2.4

2.7

24.44

25.04

mmol/l

0.65

446

(3017509) Phencyclidine [Presence] in Urine

2.86

1.50

1.3

1.6

—

(3027944) Amphetamines [Presence] in Urine

136

1120

1.23

1.50

2.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.01

1.48

1.4

—

(4268621) Lupus anticoagulant assay

227

1.51

1.46

2.4

2.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.37

1.45

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

137

1134

1.22

1.45

1.9

2.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.50

1.45

1.4

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.12

1.44

2.9

4.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.13

1.44

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1764

17239

1.14

1.43

4.0

3.8

1.26

mmol/l

0.03

1673

16287

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.73

1.43

1.2

1.5

—

(3028300) Cannabinoids [Presence] in Urine

137

1140

1.22

1.39

1.9

2.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.08

1.38

1.1

2.1

—

58223.00

—

(3020876) Protein [Mass/time] in 24 hour Urine

174

1.56

1.37

2.5

2.7

1.54

1.52

g/24h

0.01

112

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

248

1.46

1.35

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

248

1.46

1.35

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

763

1.26

1.34

1.9

1.5

—

(3028433) Virus identified in Specimen by Culture

2.05

1.26

1.0

1.2

—

(4146454) Self-monitoring of blood glucose

118

0.42

1.24

1.2

2.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

364

1.35

1.23

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

171

1.53

1.23

1.4

1.5

—

(3042517) Benzodiazepines panel - Urine

2.64

1.21

1.0

2.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

172

1.52

1.20

1.0

1.2

20.00

15.31

u/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

172

1.52

1.20

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

172

1.52

1.20

1.4

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

132

1.60

1.20

1.7

1.6

—

(3016879) Cocaine [Presence] in Urine

124

1042

1.20

1.17

2.0

2.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

544

1.28

1.16

1.4

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

438

1.31

1.16

2.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.06

1.15

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

127

1072

1.20

1.15

2.2

3.2

18.58

63.61

u/ml

3.25

122

1038

(3004451) EKG impression Narrative

1.81

1.15

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.34

1.12

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.00

1.12

1.5

1.3

0.07

0.13

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

594

1.25

1.09

2.0

2.2

3.56

4.12

iu/l

0.20

268

(3025018) Bordetella pertussis Ab [Titer] in Serum

144

1.53

1.08

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

1.59

1.08

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

164

0.55

1.08

1.0

1.8

—

993.88

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.12

1.05

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.28

1.03

1.2

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

2.28

1.03

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.74

1.02

2.2

1.2

192.00

168.25

mmol/24h

0.42

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.00

2.4

2.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

107

1.59

0.99

1.4

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

140

1.50

0.97

3.0

2.4

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

0.97

0.0

1.2

—

60.65

—

(3003694) ABO and Rh group [Type] in Blood

604

5692

1.09

0.96

1.5

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.77

0.94

1.8

36.64

45.68

ug/l

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

158

1.46

0.93

1.3

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.23

0.93

1.2

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.23

0.93

1.0

—

0.03

—

(40768441) Liver Pathology biopsy report

142

1.48

0.92

1.1

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.82

0.92

1.2

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

159

1.45

0.91

1.3

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

555

1.23

0.90

1.1

1.03

2.55

u/ml

1.96

282

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

110

1.55

0.90

1.8

2.9

43.64

44.07

0.06

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

324

1.30

0.88

2.3

2.7

92.57

95.06

ug/min

0.02

200

(3027456) Digoxin [Moles/volume] in Serum or Plasma

169

1.42

0.87

2.4

3.3

0.82

0.83

nmol/l

0.04

142

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

272

1.33

0.87

1.1

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.00

0.87

1.2

1.6

41.74

29.38

pmol/l

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

387

1.27

0.87

1.4

23.97

25.86

u/l

0.18

323

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

178

1.41

0.86

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

424

1.26

0.85

1.8

1.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.76

0.83

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

319

1.29

0.82

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.65

0.81

1.5

2.0

99.67

103.43

ng/l

0.07

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

472

1.24

0.81

1.3

1.5

0.36

0.41

nmol/l

0.33

370

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.67

0.78

1.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.78

0.0

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

308

2846

1.10

0.78

1.7

1.8

—

(4195642) Thrombophilia screening test

305

1.28

0.76

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

314

1.28

0.76

6.7

3.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.77

0.76

1.3

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

101

874

1.16

0.75

2.2

2.1

—

(3024928) Oxygen saturation in Venous blood

369

1.25

0.74

2.9

2.6

62.48

64.09

0.16

358

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.09

0.74

1.0

1.3

6.14

5.82

mmol/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

158

1.40

0.74

1.4

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.84

0.73

1.0

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.00

0.72

1.0

—

1.35

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.80

0.72

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.93

0.70

1.0

2.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

337

1.25

0.69

1.5

1.6

—

(3017354) Segmented neutrophils/Leukocytes in Blood

135

1.41

0.69

2.4

3.1

43.75

54.68

1.00

121

(3006653) Thiamine [Moles/volume] in Blood

1.53

0.69

1.0

1.3

146.38

129.56

nmol/l

0.94

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.67

0.68

1.0

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

724

1.17

0.68

3.3

3.1

2.07

1.84

mmol/l

0.26

543

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

865

1.15

0.67

3.3

3.2

5.06

5.18

kpa

0.81

839

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

567

1.19

0.67

2.4

3.1

1.46

1.36

mg/l

0.39

533

(3051611) Lipemic interference index of Serum or Plasma

153

1.38

0.67

2.1

3.2

14.73

13.67

index

0.10

108

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

0.67

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

330

1.25

0.66

1.1

1.32

3.59

eliau/ml

2.44

190

(3008757) Leukocyte morphology finding [Identifier] in Blood

128

1.41

0.65

2.3

3.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.46

0.61

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

130

1.39

0.61

1.3

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.60

0.0

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

129

1434

0.89

0.60

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.54

0.59

1.0

1.8

—

(3002256) Pathology report gross observation

253

2353

1.09

0.59

1.2

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

772

1.15

0.58

2.5

2.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.72

0.57

1.5

0.44

0.27

ug/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

420

1.20

0.56

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.51

0.56

1.2

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

160

1461

1.10

0.56

3.7

4.7

77.73

42.09

ug/l

0.19

122

1138

(3036782) Glucose [Moles/volume] in Pleural fluid

116

1.38

0.54

1.1

1.3

6.57

6.28

mmol/l

0.18

110

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.54

0.53

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

205

1.27

0.52

1.8

1.6

8.03

7.68

mmol/l

0.43

195

(3009343) pH of Capillary blood

837

1.13

0.52

3.3

3.2

7.42

0.32

690

(3022313) Gas panel - Capillary blood

597

0.85

0.52

3.9

3.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

139

1523

0.91

0.52

1.6

1010.38

1019.84

mu/l

0.04

115

1260

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

161

1.31

0.51

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

416

1.18

0.51

1.0

1.1

4.50

3.31

u/ml

0.27

202

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.50

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

550

1.15

0.48

1.6

1.5

52.33

60.21

ug/l

1.25

550

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.46

0.46

1.9

3.8

4.76

4.96

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.46

0.46

1.9

3.8

12.63

10.66

kpa

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

265

0.79

0.45

5.2

6.5

327.24

386.75

umol/l

1.18

236

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

525

1.15

0.45

3.9

4.4

43.81

854.27

u/ml

1.74

464

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

458

0.85

0.43

4.5

3.3

24.89

24.87

mmol/l

0.02

422

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.56

0.42

1.0

1.1

0.32

159.92

mg/l

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.41

0.0

1.4

—

10.83

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

752

0.89

0.41

2.2

1.8

—

(3019174) dRVVT (LA screen)

0.00

0.40

0.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

215

1.21

0.38

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.33

0.37

1.3

1.6

0.62

0.50

e9/l

0.99

(4035726) Immunohistochemistry procedure

141

1511

0.93

0.36

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

126

0.71

0.35

1.3

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.37

0.34

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

386

1.14

0.34

1.1

3.14

4.52

u/ml

0.39

170

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.36

0.34

1.5

1.2

83.50

68.05

ug/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.32

0.33

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

191

1.21

0.33

3.0

5.5

225.51

60.68

u/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

264

0.83

0.33

1.5

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

457

1.12

0.30

1.1

1.19

1.89

u/ml

0.65

216

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

109

0.73

0.29

1.4

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.23

0.29

1.0

1.9

40.66

41.25

g/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

459

1.11

0.28

1.1

—

(40768793) Breast Pathology biopsy report

508

1.11

0.28

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

140

1.22

0.27

1.2

1.5

29.38

32.16

g/l

0.37

129

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.27

0.24

1.0

1.8

—

(40768800) Prostate Pathology biopsy report

180

0.83

0.24

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

161

1.18

0.24

1.1

0.34

3.98

u/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

152

1.19

0.23

1.4

1.8

—

(3033099) Centromere Ab [Titer] in Serum

1.25

0.22

1.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

178

0.84

0.22

1.1

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

710

1.07

0.21

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.19

0.21

1.0

1.9

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.5

—

0.17

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

330.45

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

3.9

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

1.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.2

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.5

—

26.00

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

0.00

0.21

0.0

1.6

—

56.63

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

12.5

—

136.43

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.23

—

(3017569) Oxygen content in Arterial blood

1.25

0.20

1.2

3.1

15.06

16.77

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.20

0.0

2.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.23

0.20

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.23

0.20

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

417

0.91

0.20

1.2

—

(4133840) Spirometry

1.18

0.19

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

549

1.08

0.19

1.2

1.1

—

(4281824) Cell count and differential, peritoneal fluid

207

0.87

0.19

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

270

0.89

0.19

1.1

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.24

0.18

1.1

1.0

297.40

353.53

ng/l

—

(3019225) pH of Specimen

130

1358

0.95

0.18

3.8

7.35

7.36

0.31

101

993

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

845

0.94

0.17

1.8

8.30

4.63

mg/l

0.86

603

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.72

0.17

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

486

1.07

0.16

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

487

1.07

0.15

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.21

0.15

1.1

1.0

43.20

50.43

ng/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.15

0.15

1.2

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.15

0.15

1.2

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.19

0.14

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

190

0.89

0.13

1.4

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

345

1.07

0.12

2.9

3.3

19.84

24.36

mg/l

0.47

236

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

622

1.05

0.11

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

115

1.13

0.10

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.14

0.10

1.0

2.8

0.64

0.61

mmol/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.13

0.09

1.6

1.5

1.98

2.27

nmol/l

0.12

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

165

1.09

0.08

1.4

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

136

1.10

0.08

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.81

0.08

4.0

3.5

39.00

43.03

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.81

0.08

8.0

7.0

11.20

8.39

—

(3024471) HLA-A [Type]

0.81

0.08

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

401

1.05

0.08

1.6

1.4

6.17

3.96

ug/l

0.30

369

(3034426) Prothrombin time (PT)

1.06

0.08

1.3

1.2

29.29

29.06

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.12

0.07

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

214

2106

1.02

0.07

2.8

0.69

0.73

ug/l

0.25

110

1158

(3029396) Erythrocyte agglutination [Presence] in Blood

0.82

0.07

2.7

3.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

1.0

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

1.0

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

1.0

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

1.0

1.8

—

(21494434) Karyotype in Bone marrow

118

1.10

0.07

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.84

0.06

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

801

0.97

0.06

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

193

0.93

0.06

1.9

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1009

0.98

0.05

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

130

0.92

0.04

2.3

2.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.10

0.04

2.1

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

1.07

0.03

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

1.07

0.03

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

1.07

0.03

1.6

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

478

1.03

0.03

1.1

0.37

1.30

u/ml

1.53

201

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

152

1.05

0.02

1.1

1.2

105.88

116.03

pmol/l

0.60

152

(3045788) Cell count panel - Pleural fluid

106

0.94

0.01

1.4

—

(3012441) Differential panel - Pleural fluid

116

0.95

0.00

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

336

0.98

0.00

1.2

1.1

7.00

1675.52

iu/ml

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

135

1.04

0.00

1.9

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

109

1.01

0.00

1.4

3945.00

28437.88

e6/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

151

0.99

0.00

1.1

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

359

1.00

0.00

1.1

0.05

0.26

u/ml

—

110

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

138

1.01

0.00

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

497

1.01

0.00

1.1

3.06

4.91

u/ml

0.71

266

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

301.00

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.71

—

(3044007) Cell count panel - Peritoneal fluid

0.96

0.00

1.4

2.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

11.3

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.89

-0.00

3.2

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3047189) Immunofixation for 24 hour Urine

0.89

-0.00

1.2

1.9

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.98

-0.00

1.4

2.8

7.35

8.85

mmol/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.99

-0.00

1.0

1.1

—

5.79

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

4.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

5.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

0.03

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.00

-0.00

1.0

1.3

9.00

11.71

u/l

—

(40768446) Kidney Pathology biopsy report

0.92

-0.00

2.1

1.6

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.3

—

407.38

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPONDYLINFLAMNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SPONDYLINFLAMNAS	1.224 [1.04, 1.44]	0.014
Birth year	1.0 [0.99, 1.01]	0.97

During the follow-up period (1.1.1998 — 31.12.2019), 297 out of 5780 females with M13_SPONDYLINFLAMNAS died.

Males

Parameter	HR [95% CI]	p-value
M13_SPONDYLINFLAMNAS	1.518 [1.31, 1.76]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 390 out of 3635 males with M13_SPONDYLINFLAMNAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPONDYLINFLAMNAS.

N-year risk	Females	Males
1	0.084%	0.256%
5	0.817%	1.557%
10	2.133%	4.122%
15	4.094%	7.724%
20	7.452%	13.285%

Relationships between endpoints

↥

Index endpoint: M13_SPONDYLINFLAMNAS – Other specified/unspecified inflammatory spondylopathies

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specified/unspecified inflammatory spondylopathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints